Preparation of intravitreal pharmaceuticals.
\\n\\n
Released this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\\n\\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
Note: Edited in March 2021
\\n"}]',published:!0,mainMedia:null},components:[{type:"htmlEditorComponent",content:'IntechOpen is proud to announce that 191 of our authors have made the Clarivate™ Highly Cited Researchers List for 2020, ranking them among the top 1% most-cited.
\n\nThroughout the years, the list has named a total of 261 IntechOpen authors as Highly Cited. Of those researchers, 69 have been featured on the list multiple times.
\n\n\n\nReleased this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\n\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
Note: Edited in March 2021
\n'}],latestNews:[{slug:"intechopen-signs-new-contract-with-cepiec-china-for-distribution-of-open-access-books-20210319",title:"IntechOpen Signs New Contract with CEPIEC, China for Distribution of Open Access Books"},{slug:"150-million-downloads-and-counting-20210316",title:"150 Million Downloads and Counting"},{slug:"intechopen-secures-indefinite-content-preservation-with-clockss-20210309",title:"IntechOpen Secures Indefinite Content Preservation with CLOCKSS"},{slug:"intechopen-expands-to-all-global-amazon-channels-with-full-catalog-of-books-20210308",title:"IntechOpen Expands to All Global Amazon Channels with Full Catalog of Books"},{slug:"stanford-university-identifies-top-2-scientists-over-1-000-are-intechopen-authors-and-editors-20210122",title:"Stanford University Identifies Top 2% Scientists, Over 1,000 are IntechOpen Authors and Editors"},{slug:"intechopen-authors-included-in-the-highly-cited-researchers-list-for-2020-20210121",title:"IntechOpen Authors Included in the Highly Cited Researchers List for 2020"},{slug:"intechopen-maintains-position-as-the-world-s-largest-oa-book-publisher-20201218",title:"IntechOpen Maintains Position as the World’s Largest OA Book Publisher"},{slug:"all-intechopen-books-available-on-perlego-20201215",title:"All IntechOpen Books Available on Perlego"}]},book:{item:{type:"book",id:"1328",leadTitle:null,fullTitle:"Hydropower - Practice and Application",title:"Hydropower",subtitle:"Practice and Application",reviewType:"peer-reviewed",abstract:"Hydroelectric energy is the most widely used form of renewable energy, accounting for 16 percent of global electricity consumption. This book is primarily based on theoretical and applied results obtained by the authors during a long time of practice devoted to problems in the design and operation of a significant number of hydroelectric power plants in different countries. It was preferred to edit this book with the intention that it may partly serve as a supplementary textbook for students on hydropower plants. The subjects being mentioned comprise all the main components of a hydro power plant, from the upstream end, with the basin for water intake, to the downstream end of the water flow outlet.",isbn:null,printIsbn:"978-953-51-0164-2",pdfIsbn:"978-953-51-6140-0",doi:"10.5772/1798",price:139,priceEur:155,priceUsd:179,slug:"hydropower-practice-and-application",numberOfPages:334,isOpenForSubmission:!1,isInWos:1,hash:"08b3b6e6e1b5339cad8f69c9d483a594",bookSignature:"Hossein Samadi-Boroujeni",publishedDate:"March 9th 2012",coverURL:"https://cdn.intechopen.com/books/images_new/1328.jpg",numberOfDownloads:59311,numberOfWosCitations:51,numberOfCrossrefCitations:7,numberOfDimensionsCitations:50,hasAltmetrics:0,numberOfTotalCitations:108,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"March 31st 2011",dateEndSecondStepPublish:"April 28th 2011",dateEndThirdStepPublish:"September 2nd 2011",dateEndFourthStepPublish:"October 2nd 2011",dateEndFifthStepPublish:"January 30th 2012",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6,7",editedByType:"Edited by",kuFlag:!1,editors:[{id:"94088",title:"Dr.",name:"Hossein",middleName:null,surname:"Samadi-Boroujeni",slug:"hossein-samadi-boroujeni",fullName:"Hossein Samadi-Boroujeni",profilePictureURL:"https://mts.intechopen.com/storage/users/94088/images/2496_n.jpg",biography:"Dr. Hossein Samadi-Boroujeni, assistant professor at the Water Resources Research Center, Shahrekord University, has nearly 16 years of experience in the field of hydraulic structures and sediment transport. He worked as a senior manager of Dez hydropower rehabilitation project from 1999 to 2004, in Iran. He has published more than 20 papers in referred journals and more than 60 papers at international and national conferences. He has also published a Persian book on Inter-basin water transfer in 2010. He has supervised around 25 MS.c. theses at Shahrekord University since 2004.",institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Shahrekord University",institutionURL:null,country:{name:"Iran"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"770",title:"Renewable Energy",slug:"engineering-energy-engineering-renewable-energy"}],chapters:[{id:"31390",title:"Sustainable Hydropower – Issues and Approaches",doi:"10.5772/31768",slug:"sustainable-hydropower-issues-and-approaches",totalDownloads:3445,totalCrossrefCites:0,totalDimensionsCites:2,signatures:"Helen Locher and Andrew Scanlon",downloadPdfUrl:"/chapter/pdf-download/31390",previewPdfUrl:"/chapter/pdf-preview/31390",authors:[{id:"88621",title:"Dr.",name:"Helen",surname:"Locher",slug:"helen-locher",fullName:"Helen Locher"},{id:"89601",title:"Mr.",name:"Andrew",surname:"Scanlon",slug:"andrew-scanlon",fullName:"Andrew Scanlon"}],corrections:null},{id:"31391",title:"Hydropower – The Sustainability Dilemma",doi:"10.5772/34242",slug:"hydropower-the-sustainability-dilemma",totalDownloads:2158,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Wilson Cabral de Sousa Junior and Célio Bermann",downloadPdfUrl:"/chapter/pdf-download/31391",previewPdfUrl:"/chapter/pdf-preview/31391",authors:[{id:"99322",title:"Prof.",name:"Wilson",surname:"De Sousa Jr",slug:"wilson-de-sousa-jr",fullName:"Wilson De Sousa Jr"},{id:"147572",title:"Prof.",name:"Celio",surname:"Bermann",slug:"celio-bermann",fullName:"Celio Bermann"}],corrections:null},{id:"31392",title:"Hydrological Statistics for Regulating Hydropower",doi:"10.5772/34137",slug:"hydrological-statistics-for-regulating-hydropower",totalDownloads:2661,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Anders Wörman",downloadPdfUrl:"/chapter/pdf-download/31392",previewPdfUrl:"/chapter/pdf-preview/31392",authors:[{id:"98878",title:"Prof.",name:"Anders",surname:"Wörman",slug:"anders-worman",fullName:"Anders Wörman"}],corrections:null},{id:"31393",title:"Assessment of Impact of Hydropower Dams Reservoir Outflow on the Downstream River Flood Regime – Nigeria’s Experience",doi:"10.5772/33180",slug:"assessment-of-impact-of-hydropower-dams-reservoir-outflow-on-the-downstream-river-flood-regime-niger",totalDownloads:3517,totalCrossrefCites:0,totalDimensionsCites:6,signatures:"David O. Olukanni and Adebayo W. Salami",downloadPdfUrl:"/chapter/pdf-download/31393",previewPdfUrl:"/chapter/pdf-preview/31393",authors:[{id:"94356",title:"Dr.",name:"David",surname:"Olukanni",slug:"david-olukanni",fullName:"David Olukanni"},{id:"97346",title:"Dr.",name:"Adebayo",surname:"Salami",slug:"adebayo-salami",fullName:"Adebayo Salami"}],corrections:null},{id:"31394",title:"Discharge Measurement Techniques in Hydropower Systems with Emphasis on the Pressure-Time Method",doi:"10.5772/33142",slug:"some-recent-achievements-in-discharge-measurements-",totalDownloads:8012,totalCrossrefCites:1,totalDimensionsCites:5,signatures:"Adam Adamkowski",downloadPdfUrl:"/chapter/pdf-download/31394",previewPdfUrl:"/chapter/pdf-preview/31394",authors:[{id:"94197",title:"Prof.",name:"Adam",surname:"Adamkowski",slug:"adam-adamkowski",fullName:"Adam Adamkowski"}],corrections:null},{id:"31395",title:"Sediment Management in Hydropower Dam (Case Study – Dez Dam Project)",doi:"10.5772/33115",slug:"sediment-management-in-hydropower-dam-case-study-dez-dam-project-",totalDownloads:5222,totalCrossrefCites:1,totalDimensionsCites:4,signatures:"H. Samadi Boroujeni",downloadPdfUrl:"/chapter/pdf-download/31395",previewPdfUrl:"/chapter/pdf-preview/31395",authors:[{id:"94088",title:"Dr.",name:"Hossein",surname:"Samadi-Boroujeni",slug:"hossein-samadi-boroujeni",fullName:"Hossein Samadi-Boroujeni"}],corrections:null},{id:"31396",title:"Application of Microseismic Monitoring Technique in Hydroelectric Projects",doi:"10.5772/31625",slug:"application-of-microseismic-monitoring-technique-in-hydroelectric-projects",totalDownloads:4007,totalCrossrefCites:2,totalDimensionsCites:4,signatures:"Nuwen Xu, Chun’an Tang, Hong Li and Zhengzhao Liang",downloadPdfUrl:"/chapter/pdf-download/31396",previewPdfUrl:"/chapter/pdf-preview/31396",authors:[{id:"87997",title:"Dr.",name:"Nuwen",surname:"Xu",slug:"nuwen-xu",fullName:"Nuwen Xu"},{id:"97862",title:"Prof.",name:"Chun'An",surname:"Tang",slug:"chun'an-tang",fullName:"Chun'An Tang"}],corrections:null},{id:"31397",title:"Limnology of Two Contrasting Hydroelectric Reservoirs (Storage and Run-of-River) in Southeast Brazil",doi:"10.5772/31829",slug:"limnology-of-two-contrasting-hydroelectric-reservoirs-storage-and-run-of-river-in-southeast-brazil",totalDownloads:2177,totalCrossrefCites:0,totalDimensionsCites:14,signatures:"Marcos Gomes Nogueira, Gilmar Perbiche-Neves and Danilo A. O. Naliato",downloadPdfUrl:"/chapter/pdf-download/31397",previewPdfUrl:"/chapter/pdf-preview/31397",authors:[{id:"88870",title:"Prof.",name:"Marcos",surname:"Nogueira",slug:"marcos-nogueira",fullName:"Marcos Nogueira"},{id:"99645",title:"MSc.",name:"Gilmar",surname:"Perbiche-Neves",slug:"gilmar-perbiche-neves",fullName:"Gilmar Perbiche-Neves"},{id:"99647",title:"MSc.",name:"Danilo",surname:"Naliato",slug:"danilo-naliato",fullName:"Danilo Naliato"}],corrections:null},{id:"31398",title:"Reservoir Operation Applied to Hydropower Systems",doi:"10.5772/33298",slug:"reservoir-operation-applied-to-hydropower-systems",totalDownloads:3508,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"João Luiz Boccia Brandão",downloadPdfUrl:"/chapter/pdf-download/31398",previewPdfUrl:"/chapter/pdf-preview/31398",authors:[{id:"94816",title:"Dr.",name:"João",surname:"Brandão",slug:"joao-brandao",fullName:"João Brandão"}],corrections:null},{id:"31399",title:"Hydropower Scheduling in Large Scale Power Systems",doi:"10.5772/32649",slug:"hydropower-scheduling-in-large-scale-power-systems",totalDownloads:3373,totalCrossrefCites:1,totalDimensionsCites:4,signatures:"Monica Zambelli, Ivette Luna Huamani, Secundino Soares, Makoto Kadowaki and Takaaki Ohishi",downloadPdfUrl:"/chapter/pdf-download/31399",previewPdfUrl:"/chapter/pdf-preview/31399",authors:[{id:"92235",title:"Dr.",name:"Monica S.",surname:"Zambelli",slug:"monica-s.-zambelli",fullName:"Monica S. Zambelli"},{id:"99219",title:"Dr.",name:"Ivette Luna",surname:"Huamani",slug:"ivette-luna-huamani",fullName:"Ivette Luna Huamani"},{id:"99222",title:"MSc.",name:"Makoto",surname:"Kadowaki",slug:"makoto-kadowaki",fullName:"Makoto Kadowaki"},{id:"99225",title:"Prof.",name:"Takaaki",surname:"Ohishi",slug:"takaaki-ohishi",fullName:"Takaaki Ohishi"},{id:"99226",title:"Prof.",name:"Secundino",surname:"Soares",slug:"secundino-soares",fullName:"Secundino Soares"}],corrections:null},{id:"31400",title:"Fuzzy Scheduling Applied on Hydroelectric Power Generation",doi:"10.5772/34458",slug:"fuzzy-scheduling-applied-on-hydroelectric-power-generation",totalDownloads:2112,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Carlos Gracios-Marin, Gerardo Mino-Aguilar, German A. Munoz-Hernandez, José Fermi Guerrero-Castellanos, Alejandro Diaz-Sanchez, Esteban Molina Flores and Eduardo Lebano-Perez",downloadPdfUrl:"/chapter/pdf-download/31400",previewPdfUrl:"/chapter/pdf-preview/31400",authors:[{id:"27194",title:"Dr.",name:"Esteban",surname:"Molina Flores",slug:"esteban-molina-flores",fullName:"Esteban Molina Flores"},{id:"28646",title:"Dr.",name:"Gerardo",surname:"Mino-Aguilar",slug:"gerardo-mino-aguilar",fullName:"Gerardo Mino-Aguilar"},{id:"83985",title:"Dr.",name:"Carlos",surname:"Gracios-Marin",slug:"carlos-gracios-marin",fullName:"Carlos Gracios-Marin"},{id:"111745",title:"Prof.",name:"German A.",surname:"Muñoz-Hernandez",slug:"german-a.-munoz-hernandez",fullName:"German A. Muñoz-Hernandez"},{id:"111747",title:"Prof.",name:"José Fermi",surname:"Guerrero-Castellanos",slug:"jose-fermi-guerrero-castellanos",fullName:"José Fermi Guerrero-Castellanos"},{id:"111748",title:"Prof.",name:"Alejandro",surname:"Diaz-Sanchez",slug:"alejandro-diaz-sanchez",fullName:"Alejandro Diaz-Sanchez"},{id:"111753",title:"Dr.",name:"Eduardo",surname:"Lebano-Perez",slug:"eduardo-lebano-perez",fullName:"Eduardo Lebano-Perez"}],corrections:null},{id:"31401",title:"Integration of Small Hydro Turbines into Existing Water Infrastructures",doi:"10.5772/35251",slug:"integration-of-small-turbines-into-water-infrastructure",totalDownloads:7467,totalCrossrefCites:2,totalDimensionsCites:8,signatures:"Aline Choulot Vincent Denis, and Petras Punys",downloadPdfUrl:"/chapter/pdf-download/31401",previewPdfUrl:"/chapter/pdf-preview/31401",authors:[{id:"103616",title:"Prof.",name:"Petras",surname:"Punys",slug:"petras-punys",fullName:"Petras Punys"},{id:"110844",title:"MSc.",name:"Vincent",surname:"Denis",slug:"vincent-denis",fullName:"Vincent Denis"},{id:"110845",title:"MSc.",name:"Aline",surname:"Choulot",slug:"aline-choulot",fullName:"Aline Choulot"}],corrections:null},{id:"31402",title:"Project Design Management for a Large Hydropower Station",doi:"10.5772/32124",slug:"project-design-management-for-a-large-hydropower-station",totalDownloads:8900,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Xuanhua Xu, Yanju Zhou and Xiaohong Chen",downloadPdfUrl:"/chapter/pdf-download/31402",previewPdfUrl:"/chapter/pdf-preview/31402",authors:[{id:"90259",title:"Dr.",name:"Xuanhua",surname:"Xu",slug:"xuanhua-xu",fullName:"Xuanhua Xu"},{id:"136670",title:"Prof.",name:"Xiaohong",surname:"Chen",slug:"xiaohong-chen",fullName:"Xiaohong Chen"}],corrections:null},{id:"31403",title:"Damming China’s and India’s Periphery: An Overview over the Region’s Rapid Hydropower Development",doi:"10.5772/34183",slug:"damming-china-s-and-india-s-periphery-overview-over-the-regions-rapid-hydropower-development",totalDownloads:2753,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Thomas Hennig",downloadPdfUrl:"/chapter/pdf-download/31403",previewPdfUrl:"/chapter/pdf-preview/31403",authors:[{id:"99080",title:"Dr.",name:"Thomas",surname:"Hennig",slug:"thomas-hennig",fullName:"Thomas Hennig"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},relatedBooks:[{type:"book",id:"3633",title:"Solar Energy",subtitle:null,isOpenForSubmission:!1,hash:null,slug:"solar-energy",bookSignature:"Radu D Rugescu",coverURL:"https://cdn.intechopen.com/books/images_new/3633.jpg",editedByType:"Edited by",editors:[{id:"8615",title:"Prof.",name:"Radu",surname:"Rugescu",slug:"radu-rugescu",fullName:"Radu Rugescu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4479",title:"Solar Cells",subtitle:"New Approaches and Reviews",isOpenForSubmission:!1,hash:"f6907a79a7d35f34d0c719d6297a2667",slug:"solar-cells-new-approaches-and-reviews",bookSignature:"Leonid A. Kosyachenko",coverURL:"https://cdn.intechopen.com/books/images_new/4479.jpg",editedByType:"Edited by",editors:[{id:"6262",title:"Prof.",name:"Leonid A.",surname:"Kosyachenko",slug:"leonid-a.-kosyachenko",fullName:"Leonid A. Kosyachenko"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1288",title:"Solar Cells",subtitle:"Dye-Sensitized Devices",isOpenForSubmission:!1,hash:"05a255471069664ecf5fbf8778b92076",slug:"solar-cells-dye-sensitized-devices",bookSignature:"Leonid A. Kosyachenko",coverURL:"https://cdn.intechopen.com/books/images_new/1288.jpg",editedByType:"Edited by",editors:[{id:"6262",title:"Prof.",name:"Leonid A.",surname:"Kosyachenko",slug:"leonid-a.-kosyachenko",fullName:"Leonid A. Kosyachenko"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"877",title:"Third Generation Photovoltaics",subtitle:null,isOpenForSubmission:!1,hash:"c3bdfaebac38dab83a69c488bcda219d",slug:"third-generation-photovoltaics",bookSignature:"Vasilis Fthenakis",coverURL:"https://cdn.intechopen.com/books/images_new/877.jpg",editedByType:"Edited by",editors:[{id:"68723",title:"Dr.",name:"Vasilis",surname:"Fthenakis",slug:"vasilis-fthenakis",fullName:"Vasilis Fthenakis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1290",title:"Solar Cells",subtitle:"New Aspects and Solutions",isOpenForSubmission:!1,hash:"52415367e48e5b68d47325bdfc81cdce",slug:"solar-cells-new-aspects-and-solutions",bookSignature:"Leonid A. Kosyachenko",coverURL:"https://cdn.intechopen.com/books/images_new/1290.jpg",editedByType:"Edited by",editors:[{id:"6262",title:"Prof.",name:"Leonid A.",surname:"Kosyachenko",slug:"leonid-a.-kosyachenko",fullName:"Leonid A. Kosyachenko"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3118",title:"Solar Cells",subtitle:"Research and Application Perspectives",isOpenForSubmission:!1,hash:"5502d7fd7559d60419f2615615ae4cf5",slug:"solar-cells-research-and-application-perspectives",bookSignature:"Arturo Morales-Acevedo",coverURL:"https://cdn.intechopen.com/books/images_new/3118.jpg",editedByType:"Edited by",editors:[{id:"90486",title:"Prof.",name:"Arturo",surname:"Morales-Acevedo",slug:"arturo-morales-acevedo",fullName:"Arturo Morales-Acevedo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3676",title:"Solar Collectors and Panels",subtitle:"Theory and Applications",isOpenForSubmission:!1,hash:null,slug:"solar-collectors-and-panels--theory-and-applications",bookSignature:"Reccab Manyala",coverURL:"https://cdn.intechopen.com/books/images_new/3676.jpg",editedByType:"Edited by",editors:[{id:"12002",title:"Associate Prof.",name:"Reccab",surname:"Manyala",slug:"reccab-manyala",fullName:"Reccab Manyala"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1289",title:"Solar Cells",subtitle:"Silicon Wafer-Based Technologies",isOpenForSubmission:!1,hash:"76fb5123cd9acbf3c37678c5e9bd056a",slug:"solar-cells-silicon-wafer-based-technologies",bookSignature:"Leonid A. Kosyachenko",coverURL:"https://cdn.intechopen.com/books/images_new/1289.jpg",editedByType:"Edited by",editors:[{id:"6262",title:"Prof.",name:"Leonid A.",surname:"Kosyachenko",slug:"leonid-a.-kosyachenko",fullName:"Leonid A. Kosyachenko"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2154",title:"Energy Storage",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"98b5e296523724495675754b80db6245",slug:"energy-storage-technologies-and-applications",bookSignature:"Ahmed Faheem Zobaa",coverURL:"https://cdn.intechopen.com/books/images_new/2154.jpg",editedByType:"Edited by",editors:[{id:"39249",title:"Dr.",name:"Ahmed F.",surname:"Zobaa",slug:"ahmed-f.-zobaa",fullName:"Ahmed F. Zobaa"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"295",title:"Solar Cells",subtitle:"Thin-Film Technologies",isOpenForSubmission:!1,hash:"ad5cda9b208fbf385f7cdf7a5c16baae",slug:"solar-cells-thin-film-technologies",bookSignature:"Leonid A. Kosyachenko",coverURL:"https://cdn.intechopen.com/books/images_new/295.jpg",editedByType:"Edited by",editors:[{id:"6262",title:"Prof.",name:"Leonid A.",surname:"Kosyachenko",slug:"leonid-a.-kosyachenko",fullName:"Leonid A. Kosyachenko"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"73639",slug:"corrigendum-to-single-photon-emission-computed-tomography-spect-radiopharmaceuticals",title:"Corrigendum to: Single-Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/73639.pdf",downloadPdfUrl:"/chapter/pdf-download/73639",previewPdfUrl:"/chapter/pdf-preview/73639",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/73639",risUrl:"/chapter/ris/73639",chapter:{id:"73033",slug:"single-photon-emission-computed-tomography-spect-radiopharmaceuticals",signatures:"Syed Ali Raza Naqvi and Muhammad Babar Imran",dateSubmitted:"May 13th 2019",dateReviewed:"July 22nd 2020",datePrePublished:"August 21st 2020",datePublished:"January 7th 2021",book:{id:"7769",title:"Medical Isotopes",subtitle:null,fullTitle:"Medical Isotopes",slug:"medical-isotopes",publishedDate:"January 7th 2021",bookSignature:"Syed Ali Raza Naqvi and Muhammad Babar Imrani",coverURL:"https://cdn.intechopen.com/books/images_new/7769.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"259190",title:"Dr.",name:"Syed Ali Raza",middleName:null,surname:"Naqvi",slug:"syed-ali-raza-naqvi",fullName:"Syed Ali Raza Naqvi"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"259190",title:"Dr.",name:"Syed Ali Raza",middleName:null,surname:"Naqvi",fullName:"Syed Ali Raza Naqvi",slug:"syed-ali-raza-naqvi",email:"drarnaqvi@gmail.com",position:null,institution:{name:"Government College University, Faisalabad",institutionURL:null,country:{name:"Pakistan"}}},{id:"302793",title:"Dr.",name:"Muhammad Babar",middleName:null,surname:"Imran",fullName:"Muhammad Babar Imran",slug:"muhammad-babar-imran",email:"muhammadbabarimran@yahoo.com",position:null,institution:null}]}},chapter:{id:"73033",slug:"single-photon-emission-computed-tomography-spect-radiopharmaceuticals",signatures:"Syed Ali Raza Naqvi and Muhammad Babar Imran",dateSubmitted:"May 13th 2019",dateReviewed:"July 22nd 2020",datePrePublished:"August 21st 2020",datePublished:"January 7th 2021",book:{id:"7769",title:"Medical Isotopes",subtitle:null,fullTitle:"Medical Isotopes",slug:"medical-isotopes",publishedDate:"January 7th 2021",bookSignature:"Syed Ali Raza Naqvi and Muhammad Babar Imrani",coverURL:"https://cdn.intechopen.com/books/images_new/7769.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"259190",title:"Dr.",name:"Syed Ali Raza",middleName:null,surname:"Naqvi",slug:"syed-ali-raza-naqvi",fullName:"Syed Ali Raza Naqvi"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"259190",title:"Dr.",name:"Syed Ali Raza",middleName:null,surname:"Naqvi",fullName:"Syed Ali Raza Naqvi",slug:"syed-ali-raza-naqvi",email:"drarnaqvi@gmail.com",position:null,institution:{name:"Government College University, Faisalabad",institutionURL:null,country:{name:"Pakistan"}}},{id:"302793",title:"Dr.",name:"Muhammad Babar",middleName:null,surname:"Imran",fullName:"Muhammad Babar Imran",slug:"muhammad-babar-imran",email:"muhammadbabarimran@yahoo.com",position:null,institution:null}]},book:{id:"7769",title:"Medical Isotopes",subtitle:null,fullTitle:"Medical Isotopes",slug:"medical-isotopes",publishedDate:"January 7th 2021",bookSignature:"Syed Ali Raza Naqvi and Muhammad Babar Imrani",coverURL:"https://cdn.intechopen.com/books/images_new/7769.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"259190",title:"Dr.",name:"Syed Ali Raza",middleName:null,surname:"Naqvi",slug:"syed-ali-raza-naqvi",fullName:"Syed Ali Raza Naqvi"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"10658",leadTitle:null,title:"Multilingualism",subtitle:null,reviewType:"peer-reviewed",abstract:"\r\n\tMultilingualism has exerted a huge impact on people's lives all over the world. This book aims to provide the most state-of-the-art development in science and technology regarding what we have known about nature, the factors and the consequences of multilingualism and what yet we have not known. The interdisciplinary perspective will be the highlight of this book, which aims to incorporate areas of expertise from linguistics, psychology, cognitive (neuro)science, communication science, health and artificial intelligence, etc.
\r\n\r\n\tThe book will include but not be restricted to the following themes:
\r\n\r\n\t1) How multilinguals differ from monolinguals in domain-general cognitive capacities (e.g. cognitive control, social intelligence, etc.) and in the ability to produce, comprehend, acquire and use different language forms (e.g. spoken, sign, audio-visual, etc.) across contexts.
\r\n\r\n\t2) How multilinguals communicate attitudes, emotions, perceive and connect with others of different cultural/social backgrounds;
\r\n\r\n\t3) What are the processes, benefits and costs of learning multiple languages, with a special interest in people who speak underrepresented and marginalized languages and in areas where English is not the dominant language;
\r\n\r\n\t4) How being a multilingual speaker benefits or alters speaker's health, for example, in the elderly and in those who suffer from language and speech impairment;
\r\n\r\n\t5) How AI techniques have been deployed in intelligent systems to benefit multilinguals in social media connection, translation, speech recognition and multimodal sensory integration across communicative contexts.
\r\n\r\n\tThe book expects a team of authors ranging from scientists, policymakers, educators, AI engineers among others who will benefit and be benefited most from writing about multilingualism. Empirical studies, synthesized reviews, theoretical perspectives, and technical reports are welcome.
",isbn:"978-1-83969-518-6",printIsbn:"978-1-83969-517-9",pdfIsbn:"978-1-83969-519-3",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!0,hash:"a6bf171e05831c00f8687891ab1b10b5",bookSignature:"Prof. Xiaoming Jiang",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/10658.jpg",keywords:"Multilingualism, Social Communication, Cultural Norm, Accent, Psycholinguistic Processing, Learning, Cognitive Training, Language Comprehension, Language Transfer, Speech and Language Impairment, Machine Learning, Speech Recognition",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"February 15th 2021",dateEndSecondStepPublish:"March 15th 2021",dateEndThirdStepPublish:"May 14th 2021",dateEndFourthStepPublish:"August 2nd 2021",dateEndFifthStepPublish:"October 1st 2021",remainingDaysToSecondStep:"a month",secondStepPassed:!0,currentStepOfPublishingProcess:3,editedByType:null,kuFlag:!1,biosketch:"Dr. Xiaoming Jiang obtained his Ph.D. degree in Cognitive Neuroscience from Peking University, China. He worked as a research fellow in the School of Communication Sciences and Disorders, McGill University, and was then a senior speech scientist in the natural language understanding team in Nuance Communication.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"189844",title:"Prof.",name:"Xiaoming",middleName:null,surname:"Jiang",slug:"xiaoming-jiang",fullName:"Xiaoming Jiang",profilePictureURL:"https://mts.intechopen.com/storage/users/189844/images/system/189844.jpg",biography:"Dr. Xiaoming Jiang is a professor in the Institute of Linguistics, Shanghai International Studies University. He obtained his BS degree in Psychology from the East China Normal University and his Ph.D. degree in Cognitive Neuroscience from Peking University. He worked as a research fellow in the School of Communication Sciences and Disorders, McGill University and was then a senior speech scientist in the natural language understanding team in Nuance Communication. His research utilizes experimental methodologies to uncover social aspects of human speech and language processes. While serving as reviewer for nearly 30 international journals, he has published 30 peer-reviewed articles as a leading author on high-impact journals including NeuroImage; Human Brain Mapping; Social, Cognitive and Affective Neuroscience; Cortex; Journal of Experimental Psychology: Human Perception and Performance; Neuropsychologia; Quarterly Journal of Experimental Psychology and Speech Communication. His research on speaker confidence and trustworthiness has been media-covered by the Forbes and the New Scientist.",institutionString:"Shanghai International Studies University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"4",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Shanghai International Studies University",institutionURL:null,country:{name:"China"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"23",title:"Social Sciences",slug:"social-sciences"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"347258",firstName:"Marica",lastName:"Novakovic",middleName:null,title:"Ms.",imageUrl:"//cdnintech.com/web/frontend/www/assets/author.svg",email:"marica@intechopen.com",biography:null}},relatedBooks:[{type:"book",id:"5726",title:"Sociolinguistics",subtitle:"Interdisciplinary Perspectives",isOpenForSubmission:!1,hash:"e87ee120f901a00564a230234d9e3ed5",slug:"sociolinguistics-interdisciplinary-perspectives",bookSignature:"Xiaoming Jiang",coverURL:"https://cdn.intechopen.com/books/images_new/5726.jpg",editedByType:"Edited by",editors:[{id:"189844",title:"Prof.",name:"Xiaoming",surname:"Jiang",slug:"xiaoming-jiang",fullName:"Xiaoming Jiang"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6942",title:"Global Social Work",subtitle:"Cutting Edge Issues and Critical Reflections",isOpenForSubmission:!1,hash:"222c8a66edfc7a4a6537af7565bcb3de",slug:"global-social-work-cutting-edge-issues-and-critical-reflections",bookSignature:"Bala Raju Nikku",coverURL:"https://cdn.intechopen.com/books/images_new/6942.jpg",editedByType:"Edited by",editors:[{id:"263576",title:"Dr.",name:"Bala",surname:"Nikku",slug:"bala-nikku",fullName:"Bala Nikku"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"314",title:"Regenerative Medicine and Tissue Engineering",subtitle:"Cells and Biomaterials",isOpenForSubmission:!1,hash:"bb67e80e480c86bb8315458012d65686",slug:"regenerative-medicine-and-tissue-engineering-cells-and-biomaterials",bookSignature:"Daniel Eberli",coverURL:"https://cdn.intechopen.com/books/images_new/314.jpg",editedByType:"Edited by",editors:[{id:"6495",title:"Dr.",name:"Daniel",surname:"Eberli",slug:"daniel-eberli",fullName:"Daniel Eberli"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"26504",title:"The SUMOylation Pathway as a Potential Therapeutic Target in Multiple Myeloma",doi:"10.5772/31013",slug:"the-sumoylation-pathway-as-a-potential-therapeutic-target-in-multiple-myeloma",body:null,keywords:null,chapterPDFUrl:"https://cdn.intechopen.com/pdfs/26504.pdf",chapterXML:null,downloadPdfUrl:"/chapter/pdf-download/26504",previewPdfUrl:"/chapter/pdf-preview/26504",totalDownloads:2415,totalViews:68,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,dateSubmitted:"March 24th 2011",dateReviewed:"September 5th 2011",datePrePublished:null,datePublished:"January 20th 2012",dateFinished:null,readingETA:"0",abstract:null,reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/26504",risUrl:"/chapter/ris/26504",book:{slug:"multiple-myeloma-an-overview"},signatures:"James J. Driscoll",authors:[{id:"85219",title:"Dr.",name:"James",middleName:null,surname:"Driscoll",fullName:"James Driscoll",slug:"james-driscoll",email:"driscollj@mail.nih.gov",position:null,institution:{name:"National Cancer Institute",institutionURL:null,country:{name:"United States of America"}}}],sections:null,chapterReferences:null,footnotes:null,contributors:null,corrections:null},book:{id:"732",title:"Multiple Myeloma",subtitle:"An Overview",fullTitle:"Multiple Myeloma - An Overview",slug:"multiple-myeloma-an-overview",publishedDate:"January 20th 2012",bookSignature:"Ajay Gupta",coverURL:"https://cdn.intechopen.com/books/images_new/732.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"93784",title:"Dr.",name:"Ajay",middleName:null,surname:"Gupta",slug:"ajay-gupta",fullName:"Ajay Gupta"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"26499",title:"Proteasome Inhibitors in the Treatment of Multiple Myeloma",slug:"targeting-the-proteasome-in-myeloma-current-achievements-and-future-prospects-",totalDownloads:2694,totalCrossrefCites:0,signatures:"Lisa J. Crawford and Alexandra E. Irvine",authors:[{id:"88220",title:"Dr.",name:"Alexandra",middleName:null,surname:"Irvine",fullName:"Alexandra Irvine",slug:"alexandra-irvine"}]},{id:"26500",title:"Regulatory Cells and Multiple Myeloma",slug:"regulatory-cells-and-multiple-myeloma",totalDownloads:2044,totalCrossrefCites:1,signatures:"Karthick Raja Muthu Raja and Roman Hajek",authors:[{id:"86052",title:"Dr.",name:"Karthick Raja",middleName:null,surname:"Muthu Raja",fullName:"Karthick Raja Muthu Raja",slug:"karthick-raja-muthu-raja"},{id:"92830",title:"Prof.",name:"Roman",middleName:null,surname:"Hajek",fullName:"Roman Hajek",slug:"roman-hajek"}]},{id:"26501",title:"Effects of Recombinant Human Tumor Necrosis Factor-α and Its Combination with Native Human Leukocyte Interferon-α on P3-X63- Ag8.653 Mouse Myeloma Cell Growth",slug:"effects-of-recombinant-human-tumor-necrosis-factor-and-its-combination-with-native-human-leukocyte-i",totalDownloads:1857,totalCrossrefCites:0,signatures:"Andrej Plesničar, Gaj Vidmar, Borut Štabuc and Blanka Kores Plesničar",authors:[{id:"72209",title:"Dr.",name:"Gaj",middleName:null,surname:"Vidmar",fullName:"Gaj Vidmar",slug:"gaj-vidmar"},{id:"85551",title:"Dr.",name:"Andrej",middleName:null,surname:"Plesnicar",fullName:"Andrej Plesnicar",slug:"andrej-plesnicar"},{id:"93202",title:"Prof.",name:"Borut",middleName:null,surname:"Štabuc",fullName:"Borut Štabuc",slug:"borut-stabuc"},{id:"93203",title:"Prof.",name:"Blanka",middleName:null,surname:"Kores Plesničar",fullName:"Blanka Kores Plesničar",slug:"blanka-kores-plesnicar"}]},{id:"26502",title:"Cellular Immunotherapy Using Dendritic Cells Against Multiple Myeloma",slug:"cellular-immunotherapy-using-dendritic-cells-against-multiple-myeloma",totalDownloads:1335,totalCrossrefCites:0,signatures:"Je-Jung Lee, Youn-Kyung Lee and Thanh-Nhan Nguyen-Pham",authors:[{id:"83521",title:"Prof.",name:"Je-Jung",middleName:null,surname:"Lee",fullName:"Je-Jung Lee",slug:"je-jung-lee"}]},{id:"26503",title:"Targeted Inhibition of Multiple Proinflammatory Signalling Pathways for the Prevention and Treatment of Multiple Myeloma",slug:"targeted-inhibition-of-multiple-proinflammatory-signaling-pathways-for-the-prevention-and-treatment-",totalDownloads:1403,totalCrossrefCites:2,signatures:"Radhamani Kannaiyan, Rohit Surana, Eun Myoung Shin, Lalitha Ramachandran, Gautam Sethi and Alan Prem Kumar",authors:[{id:"82594",title:"Dr.",name:"Alan",middleName:"Prem",surname:"Kumar",fullName:"Alan Kumar",slug:"alan-kumar"},{id:"91478",title:"Ms.",name:"Radhamani",middleName:null,surname:"Kannaiyan",fullName:"Radhamani Kannaiyan",slug:"radhamani-kannaiyan"},{id:"91483",title:"Mr.",name:"Rohit",middleName:null,surname:"Surana",fullName:"Rohit Surana",slug:"rohit-surana"},{id:"91486",title:"Dr.",name:"Eun Myoung",middleName:null,surname:"Shin",fullName:"Eun Myoung Shin",slug:"eun-myoung-shin"},{id:"91489",title:"Dr.",name:"Gautam",middleName:null,surname:"Sethi",fullName:"Gautam Sethi",slug:"gautam-sethi"},{id:"126188",title:"Ms.",name:"Lalitha",middleName:null,surname:"Ramachandran",fullName:"Lalitha Ramachandran",slug:"lalitha-ramachandran"}]},{id:"26504",title:"The SUMOylation Pathway as a Potential Therapeutic Target in Multiple Myeloma",slug:"the-sumoylation-pathway-as-a-potential-therapeutic-target-in-multiple-myeloma",totalDownloads:2415,totalCrossrefCites:0,signatures:"James J. Driscoll",authors:[{id:"85219",title:"Dr.",name:"James",middleName:null,surname:"Driscoll",fullName:"James Driscoll",slug:"james-driscoll"}]},{id:"26505",title:"Therapeutic Approaches for Targeting Hypoxia- Inducible Factor in Multiple Myeloma",slug:"therapeutic-approaches-for-targeting-hypoxia-inducible-factor-in-multiple-myeloma",totalDownloads:1811,totalCrossrefCites:1,signatures:"Keita Kirito",authors:[{id:"85256",title:"Dr.",name:"Keita",middleName:null,surname:"Kirito",fullName:"Keita Kirito",slug:"keita-kirito"}]},{id:"26506",title:"Chapter 8\tThe Contribution of Prognostic Factors to the Better Management of Multiple Myeloma Patients",slug:"the-contribution-of-prognostic-factors-to-the-better-management-of-multiple-myeloma-patients",totalDownloads:1597,totalCrossrefCites:1,signatures:"Marie-Christine Kyrtsonis, Dimitrios Maltezas, Efstathios Koulieris, Katerina Bitsani, Ilias Pessach, Anna Efthymiou, Vassiliki Bartzis, Tatiana Tzenou and Panayiotis Panayiotidis",authors:[{id:"82522",title:"Prof.",name:"Marie-Christine",middleName:null,surname:"Kyrtsonis",fullName:"Marie-Christine Kyrtsonis",slug:"marie-christine-kyrtsonis"}]},{id:"26507",title:"Solitary Plasmacytoma of Bone",slug:"solitary-plasmacytoma-of-bone",totalDownloads:3461,totalCrossrefCites:0,signatures:"Jianru Xiao, Wending Huang, Xinghai Yang and Honglin Teng",authors:[{id:"85559",title:"Prof.",name:"Jianru",middleName:null,surname:"Xiao",fullName:"Jianru Xiao",slug:"jianru-xiao"},{id:"124109",title:"Dr.",name:"Wending",middleName:null,surname:"Huang",fullName:"Wending Huang",slug:"wending-huang"},{id:"124117",title:"Dr.",name:"Xinghai",middleName:null,surname:"Yang",fullName:"Xinghai Yang",slug:"xinghai-yang"},{id:"124119",title:"Dr.",name:"Honglin",middleName:null,surname:"Teng",fullName:"Honglin Teng",slug:"honglin-teng"}]},{id:"26508",title:"Solitary Bone and Extramedullary Plasmacytoma",slug:"plasmocytoma",totalDownloads:4349,totalCrossrefCites:1,signatures:"Galina Salogub, Ekaterina Lokhmatova and Sergey Sozin",authors:[{id:"83539",title:"PhD.",name:"Galina",middleName:null,surname:"Salogub",fullName:"Galina Salogub",slug:"galina-salogub"}]},{id:"26509",title:"Multiple Myeloma and Dentistry",slug:"multiple-myeloma-and-dentistry",totalDownloads:21569,totalCrossrefCites:5,signatures:"Ajaz Shah, Suhail Latoo and Irshad Ahmad",authors:[{id:"83575",title:"Prof.",name:"Ajaz",middleName:null,surname:"Shah",fullName:"Ajaz Shah",slug:"ajaz-shah"},{id:"87422",title:"Dr.",name:"Suhail",middleName:null,surname:"Latoo",fullName:"Suhail Latoo",slug:"suhail-latoo"},{id:"136894",title:"Dr.",name:"Irshad",middleName:null,surname:"Ahmad",fullName:"Irshad Ahmad",slug:"irshad-ahmad"}]},{id:"26510",title:"Renal Disease in Multiple Myeloma",slug:"renal-disease-in-multiple-myeloma",totalDownloads:4316,totalCrossrefCites:0,signatures:"Guray Saydam, Fahri Sahin and Hatice Demet Kiper",authors:[{id:"94230",title:"Prof.",name:"Guray",middleName:null,surname:"Saydam",fullName:"Guray Saydam",slug:"guray-saydam"},{id:"94231",title:"Prof.",name:"Fahri",middleName:null,surname:"Sahin",fullName:"Fahri Sahin",slug:"fahri-sahin"},{id:"94232",title:"Dr.",name:"Hatice Demet",middleName:null,surname:"Kiper",fullName:"Hatice Demet Kiper",slug:"hatice-demet-kiper"}]},{id:"26511",title:"Stem Cell Mobılızatıon in Multıple Myeloma",slug:"stem-cell-mobilization-in-patients-with-multiple-myeloma",totalDownloads:2269,totalCrossrefCites:0,signatures:"Şule Mine Bakanay and Taner Demirer",authors:[{id:"84241",title:"Prof.",name:"Taner",middleName:null,surname:"Demirer",fullName:"Taner Demirer",slug:"taner-demirer"},{id:"84294",title:"Dr.",name:"Şule Mine",middleName:null,surname:"Bakanay",fullName:"Şule Mine Bakanay",slug:"sule-mine-bakanay"}]},{id:"26512",title:"The Current Role of Stem Cell Transplantation in Multiple Myeloma",slug:"the-current-role-of-stem-cell-transplantation-in-multiple-myeloma",totalDownloads:1386,totalCrossrefCites:0,signatures:"Ajay Gupta",authors:[{id:"93784",title:"Dr.",name:"Ajay",middleName:null,surname:"Gupta",fullName:"Ajay Gupta",slug:"ajay-gupta"}]}]},relatedBooks:[{type:"book",id:"209",title:"Cancer Stem Cells",subtitle:"The Cutting Edge",isOpenForSubmission:!1,hash:"464a7be74679b09faeb4aef72c3cd3a6",slug:"cancer-stem-cells-the-cutting-edge",bookSignature:"Stanley Shostak",coverURL:"https://cdn.intechopen.com/books/images_new/209.jpg",editedByType:"Edited by",editors:[{id:"28104",title:"Prof.",name:"Stanley",surname:"Shostak",slug:"stanley-shostak",fullName:"Stanley Shostak"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"17322",title:"Stem Cells and Cancer Stem Cells",slug:"stem-cells-and-cancer-stem-cells",signatures:"Lucinei Roberto Oliveira, Andrielle de Castilho Fernandes and Alfredo Ribeiro-Silva",authors:[{id:"30977",title:"Prof.",name:"Alfredo",middleName:null,surname:"Ribeiro-Silva",fullName:"Alfredo Ribeiro-Silva",slug:"alfredo-ribeiro-silva"}]},{id:"17323",title:"Clinical Significance of Putative Cancer Stem Cells in Residual Cancer Cells After Chemoradiotherapy for Rectal Cancer",slug:"clinical-significance-of-putative-cancer-stem-cells-in-residual-cancer-cells-after-chemoradiotherapy",signatures:"Koji Tanaka, Yasuhiro Inoue, Yuji Toiyama, Keiichi Uchida, Chikao Miki and Masato Kusunoki",authors:[{id:"31129",title:"Dr",name:"Koji",middleName:null,surname:"Tanaka",fullName:"Koji Tanaka",slug:"koji-tanaka"},{id:"44028",title:"Dr.",name:"Yasuhiro",middleName:null,surname:"Inoue",fullName:"Yasuhiro Inoue",slug:"yasuhiro-inoue"},{id:"44029",title:"Dr.",name:"Yuji",middleName:null,surname:"Toiyama",fullName:"Yuji Toiyama",slug:"yuji-toiyama"},{id:"44030",title:"Dr.",name:"Keiichi",middleName:null,surname:"Uchida",fullName:"Keiichi Uchida",slug:"keiichi-uchida"},{id:"44031",title:"Dr.",name:"Chikao",middleName:null,surname:"Miki",fullName:"Chikao Miki",slug:"chikao-miki"},{id:"44032",title:"Prof.",name:"Masato",middleName:null,surname:"Kusunoki",fullName:"Masato Kusunoki",slug:"masato-kusunoki"}]},{id:"17324",title:"Cancer Stem Cells in Solid Organ Malignancies: Mechanisms of Treatment Resistance and Strategies for Therapeutic Targeting",slug:"cancer-stem-cells-in-solid-organ-malignancies-mechanisms-of-treatment-resistance-and-strategies-for-",signatures:"Marcus M. Monroe, Crystal J. Hessman, Daniel R. Clayburgh, Emily J. Bubbers and Melissa H. Wong",authors:[{id:"42352",title:"Dr.",name:"Melissa",middleName:null,surname:"Wong",fullName:"Melissa Wong",slug:"melissa-wong"},{id:"55368",title:"Dr.",name:"Marcus",middleName:"M",surname:"Monroe",fullName:"Marcus Monroe",slug:"marcus-monroe"},{id:"55369",title:"Dr.",name:"Daniel",middleName:null,surname:"Clayburgh",fullName:"Daniel Clayburgh",slug:"daniel-clayburgh"},{id:"55370",title:"Dr.",name:"Crystal",middleName:null,surname:"Hessman",fullName:"Crystal Hessman",slug:"crystal-hessman"},{id:"55371",title:"Dr.",name:"Emily",middleName:null,surname:"Bubbers",fullName:"Emily Bubbers",slug:"emily-bubbers"},{id:"55372",title:"Dr.",name:"Eric",middleName:null,surname:"Anderson",fullName:"Eric Anderson",slug:"eric-anderson"}]},{id:"17325",title:"Cancer Initiating Cells in Head and Neck Squamous Cell Carcinoma",slug:"cancer-initiating-cells-in-head-and-neck-squamous-cell-carcinoma",signatures:"Jesús M. Paramio",authors:[{id:"34513",title:"Prof.",name:"Jesus M",middleName:null,surname:"Paramio",fullName:"Jesus M Paramio",slug:"jesus-m-paramio"}]},{id:"17326",title:"Stem Cell Growth as a Model of Carcinogenesis",slug:"stem-cell-growth-as-a-model-of-carcinogenesis",signatures:"Steven Poser, Joseph Alisky, Kuei-Fang Chung, Doreen Ebermann, Monika Ehrhart-Bornstein, Stefan Bornstein and Andreas Androutsellis-Theotokis",authors:[{id:"31989",title:"Dr.",name:"Andreas",middleName:null,surname:"Androutsellis-Theotokis",fullName:"Andreas Androutsellis-Theotokis",slug:"andreas-androutsellis-theotokis"},{id:"43580",title:"Dr.",name:"Steve",middleName:null,surname:"Poser",fullName:"Steve Poser",slug:"steve-poser"},{id:"43581",title:"Dr.",name:"Joseph",middleName:"Martin",surname:"Alisky",fullName:"Joseph Alisky",slug:"joseph-alisky"},{id:"43582",title:"Dr.",name:"Kuei-Fang",middleName:null,surname:"Chung",fullName:"Kuei-Fang Chung",slug:"kuei-fang-chung"},{id:"43583",title:"Dr.",name:"Monika",middleName:null,surname:"Ehrhart-Bornstein",fullName:"Monika Ehrhart-Bornstein",slug:"monika-ehrhart-bornstein"},{id:"43584",title:"Prof.",name:"Stefan",middleName:null,surname:"Bornstein",fullName:"Stefan Bornstein",slug:"stefan-bornstein"},{id:"69804",title:"Ms.",name:"Doreen",middleName:null,surname:"Ebermann",fullName:"Doreen Ebermann",slug:"doreen-ebermann"}]},{id:"17327",title:"Cancer Stem Cells in Multiple Myeloma",slug:"cancer-stem-cells-in-multiple-myeloma",signatures:"Sabino Ciavarella, Annalisa Milano, Annalisa Savonarola, Oronzo Brunetti, Franco Dammacco and Franco Silvestris",authors:[{id:"32157",title:"Dr.",name:"Franco",middleName:null,surname:"Silvestris",fullName:"Franco Silvestris",slug:"franco-silvestris"},{id:"45482",title:"Dr.",name:"Sabino",middleName:null,surname:"Ciavarella",fullName:"Sabino Ciavarella",slug:"sabino-ciavarella"},{id:"45483",title:"Dr.",name:"Annalisa",middleName:null,surname:"Milano",fullName:"Annalisa Milano",slug:"annalisa-milano"},{id:"45484",title:"Dr.",name:"Oronzo",middleName:null,surname:"Brunetti",fullName:"Oronzo Brunetti",slug:"oronzo-brunetti"},{id:"96505",title:"Dr.",name:"Annalisa",middleName:null,surname:"Savonarola",fullName:"Annalisa Savonarola",slug:"annalisa-savonarola"},{id:"96507",title:"Prof.",name:"Franco",middleName:null,surname:"Dammacco",fullName:"Franco Dammacco",slug:"franco-dammacco"}]},{id:"17328",title:"Systems and Network Understanding of Cancer Stem Cells",slug:"systems-and-network-understanding-of-cancer-stem-cells",signatures:"Asfar S. Azmi, Ramzi M. Mohammad, Sanjeev Banerjee, Zhiwei Wang, Bin Bao and Fazlul H. Sarkar",authors:[{id:"31486",title:"Prof.",name:"Fazlul",middleName:null,surname:"Sarkar",fullName:"Fazlul Sarkar",slug:"fazlul-sarkar"},{id:"40173",title:"Dr.",name:"Asfar",middleName:null,surname:"Azmi",fullName:"Asfar Azmi",slug:"asfar-azmi"},{id:"40174",title:"Prof.",name:"Ramzi",middleName:null,surname:"Mohammad",fullName:"Ramzi Mohammad",slug:"ramzi-mohammad"}]},{id:"17329",title:"What do We Know About Cancer Stem Cells? Utilizing Colon Cancer as an Example",slug:"what-do-we-know-about-cancer-stem-cells-utilizing-colon-cancer-as-an-example",signatures:"Benhaim Leonor, Labonte Melissa and Lenz Heinz-Joseph",authors:[{id:"35269",title:"Prof.",name:"Leonor",middleName:null,surname:"Benhaim",fullName:"Leonor Benhaim",slug:"leonor-benhaim"},{id:"83265",title:"Dr.",name:"Melissa",middleName:null,surname:"Labonte",fullName:"Melissa Labonte",slug:"melissa-labonte"},{id:"83266",title:"Dr.",name:"Heinz-Joseph",middleName:null,surname:"Lenz",fullName:"Heinz-Joseph Lenz",slug:"heinz-joseph-lenz"}]},{id:"17330",title:"Epithelial-Mesenchymal Transition and Cancer Stem Cells",slug:"epithelial-mesenchymal-transition-and-cancer-stem-cells",signatures:"Gaoliang Ouyang",authors:[{id:"34355",title:"Prof.",name:"Gaoliang",middleName:null,surname:"Ouyang",fullName:"Gaoliang Ouyang",slug:"gaoliang-ouyang"}]},{id:"17331",title:"Cancer Stem Cell Niche: The Role of Mesenchymal Stem Cells in Tumor Microenvironment 189",slug:"cancer-stem-cell-niche-the-role-of-mesenchymal-stem-cells-in-tumor-microenvironment-189",signatures:"Kanya Honoki, Hiromasa Fujii and Toshifumi Tsujiuchi",authors:[{id:"28035",title:"Associate Prof.",name:"Kanya",middleName:null,surname:"Honoki",fullName:"Kanya Honoki",slug:"kanya-honoki"},{id:"28447",title:"Dr.",name:"Hiromasa",middleName:null,surname:"Fujii",fullName:"Hiromasa Fujii",slug:"hiromasa-fujii"},{id:"28448",title:"Dr.",name:"Toshifumi",middleName:null,surname:"Tsujiuchi",fullName:"Toshifumi Tsujiuchi",slug:"toshifumi-tsujiuchi"}]},{id:"17332",title:"Transformation of Mesenchymal Stem Cells",slug:"transformation-of-mesenchymal-stem-cells",signatures:"Nedime Serakinci, Rikke Christensen and Umut Fahrioglu",authors:[{id:"31274",title:"Prof.",name:"Nedime",middleName:null,surname:"Serakinci",fullName:"Nedime Serakinci",slug:"nedime-serakinci"},{id:"44561",title:"Dr",name:"Umut",middleName:null,surname:"Fahrioglu",fullName:"Umut Fahrioglu",slug:"umut-fahrioglu"},{id:"44562",title:"Dr.",name:"Rikke",middleName:null,surname:"Christensen",fullName:"Rikke Christensen",slug:"rikke-christensen"}]},{id:"17333",title:"Brain Tumor Stem Cells and Anti-Angiogenic Therapy",slug:"brain-tumor-stem-cells-and-anti-angiogenic-therapy",signatures:"Katsuya Saito, Kazunari Yoshida and Masahiro Toda",authors:[{id:"43604",title:"Prof.",name:"Masahiro",middleName:null,surname:"Toda",fullName:"Masahiro Toda",slug:"masahiro-toda"},{id:"43608",title:"Dr",name:"Katsuya",middleName:null,surname:"Saito",fullName:"Katsuya Saito",slug:"katsuya-saito"}]},{id:"17334",title:"Targeting Glioma Stem Cells: Path Leading to the Cure",slug:"targeting-glioma-stem-cells-path-leading-to-the-cure",signatures:"Ke Sai and Zhong-ping Chen",authors:[{id:"36540",title:"Prof.",name:"Zhong-ping",middleName:null,surname:"Chen",fullName:"Zhong-ping Chen",slug:"zhong-ping-chen"},{id:"43961",title:"Dr.",name:"Ke",middleName:null,surname:"Sai",fullName:"Ke Sai",slug:"ke-sai"}]},{id:"17335",title:"Glioma Stem Cells",slug:"glioma-stem-cells",signatures:"Ryan Y. Kim, Ali Mahta and Santosh Kesari",authors:[{id:"48513",title:"Dr.",name:"Santosh",middleName:null,surname:"Kesari",fullName:"Santosh Kesari",slug:"santosh-kesari"},{id:"48522",title:"Mr",name:"Ryan",middleName:null,surname:"Kim",fullName:"Ryan Kim",slug:"ryan-kim"}]},{id:"17336",title:"Regulation of Glioma Stem Cells by the Notch Signaling Pathway: Mechanisms and Therapeutic Implications",slug:"regulation-of-glioma-stem-cells-by-the-notch-signaling-pathway-mechanisms-and-therapeutic-implicatio",signatures:"Hong-Yan Qin, Luo-An Fu and Hua Han",authors:[{id:"42904",title:"Prof.",name:"Hua",middleName:null,surname:"Han",fullName:"Hua Han",slug:"hua-han"},{id:"42905",title:"Prof.",name:"Hong-Yan",middleName:null,surname:"Qin",fullName:"Hong-Yan Qin",slug:"hong-yan-qin"},{id:"85978",title:"Dr.",name:"Luo-An",middleName:null,surname:"Fu",fullName:"Luo-An Fu",slug:"luo-an-fu"}]},{id:"17337",title:"The Hedgehog Signaling Network and the Development of Gastric Cancer",slug:"the-hedgehog-signaling-network-and-the-development-of-gastric-cancer",signatures:"Jessica M. Donnelly, JeanMarie Houghton and Yana Zavros",authors:[{id:"49368",title:"Dr.",name:"Yana",middleName:null,surname:"Zavros",fullName:"Yana Zavros",slug:"yana-zavros"}]},{id:"17338",title:"Differentiation of Cancer Stem Cells",slug:"differentiation-of-cancer-stem-cells",signatures:"Taro Yamashita, Masao Honda and Shuichi Kaneko",authors:[{id:"27817",title:"Dr.",name:"Taro",middleName:null,surname:"Yamashita",fullName:"Taro Yamashita",slug:"taro-yamashita"},{id:"43187",title:"Dr.",name:"Masao",middleName:null,surname:"Honda",fullName:"Masao Honda",slug:"masao-honda"},{id:"43188",title:"Dr.",name:"Shuichi",middleName:null,surname:"Kaneko",fullName:"Shuichi Kaneko",slug:"shuichi-kaneko"}]},{id:"17339",title:"Carbohydrate Antigens as Cancer-Initiating Cell Markers",slug:"carbohydrate-antigens-as-cancer-initiating-cell-markers",signatures:"Wei-Ming Lin, Uwe Karsten, Steffen Goletz and Yi Cao",authors:[{id:"51917",title:"Prof.",name:"Yi",middleName:null,surname:"Cao",fullName:"Yi Cao",slug:"yi-cao"},{id:"52594",title:"Dr.",name:"Wei-Ming",middleName:null,surname:"Lin",fullName:"Wei-Ming Lin",slug:"wei-ming-lin"},{id:"52595",title:"Dr.",name:"Uwe",middleName:null,surname:"Karsten",fullName:"Uwe Karsten",slug:"uwe-karsten"},{id:"52596",title:"Dr.",name:"Steffen",middleName:null,surname:"Goletz",fullName:"Steffen Goletz",slug:"steffen-goletz"}]},{id:"17340",title:"Influence of Culture Environment and Mollicutes Contaminations on CD133 Modulation in Cancer Stem Cells",slug:"influence-of-culture-environment-and-mollicutes-contaminations-on-cd133-modulation-in-cancer-stem-ce",signatures:"Elisabetta Mariotti, Peppino Mirabelli, Francesca D’Alessio, Marica Gemei, Rosa Di Noto, Giuliana Fortunato and Luigi Del Vecchio",authors:[{id:"28066",title:"Dr.",name:"Rosa",middleName:null,surname:"Di Noto",fullName:"Rosa Di Noto",slug:"rosa-di-noto"},{id:"44267",title:"Dr.",name:"Elisabetta",middleName:null,surname:"Mariotti",fullName:"Elisabetta Mariotti",slug:"elisabetta-mariotti"},{id:"44268",title:"Dr.",name:"Peppino",middleName:null,surname:"Mirabelli",fullName:"Peppino Mirabelli",slug:"peppino-mirabelli"},{id:"44269",title:"Dr.",name:"Francesca",middleName:null,surname:"D'Alessio",fullName:"Francesca D'Alessio",slug:"francesca-d'alessio"},{id:"44270",title:"Dr.",name:"Marica",middleName:null,surname:"Gemei",fullName:"Marica Gemei",slug:"marica-gemei"},{id:"44271",title:"Prof.",name:"Giuliana",middleName:null,surname:"Fortunato",fullName:"Giuliana Fortunato",slug:"giuliana-fortunato"},{id:"44272",title:"Prof.",name:"Luigi",middleName:null,surname:"Del Vecchio",fullName:"Luigi Del Vecchio",slug:"luigi-del-vecchio"}]},{id:"17341",title:"Therapeutic Strategies Targeting Cancer Stem Cells",slug:"therapeutic-strategies-targeting-cancer-stem-cells",signatures:"Atique U. Ahmed, Bart Thaci, Derek A. Wainwright, Mahua Dey and Maciej S. Lesniak",authors:[{id:"33310",title:"Dr.",name:"Maciej",middleName:null,surname:"Lesniak",fullName:"Maciej Lesniak",slug:"maciej-lesniak"},{id:"83065",title:"Dr.",name:"Atique",middleName:null,surname:"Ahmed",fullName:"Atique Ahmed",slug:"atique-ahmed"},{id:"83066",title:"Dr.",name:"Bart",middleName:null,surname:"Thaci",fullName:"Bart Thaci",slug:"bart-thaci"},{id:"83067",title:"Dr.",name:"Derek",middleName:null,surname:"Wainwright",fullName:"Derek Wainwright",slug:"derek-wainwright"},{id:"83068",title:"Dr.",name:"Mahua",middleName:null,surname:"Dey",fullName:"Mahua Dey",slug:"mahua-dey"}]},{id:"17342",title:"Latest Therapeutic Approaches Based on Cancer Stem Cells",slug:"latest-therapeutic-approaches-based-on-cancer-stem-cells",signatures:"Dou Jun, Wang Jing and Gu Ning",authors:[{id:"27777",title:"Prof.",name:"Jun",middleName:null,surname:"Dou",fullName:"Jun Dou",slug:"jun-dou"}]},{id:"17343",title:"Potential Application of Natural Dietary Components to Target Cancer Stem Cells",slug:"potential-application-of-natural-dietary-components-to-target-cancer-stem-cells",signatures:"Yanyan Li, Steven J. Schwartz and Duxin Sun",authors:[{id:"31751",title:"Dr",name:"Yanyan",middleName:null,surname:"Li",fullName:"Yanyan Li",slug:"yanyan-li"},{id:"32401",title:"Dr.",name:"Steven",middleName:null,surname:"Schwartz",fullName:"Steven Schwartz",slug:"steven-schwartz"},{id:"37219",title:"Dr.",name:"Duxin",middleName:null,surname:"Sun",fullName:"Duxin Sun",slug:"duxin-sun"}]},{id:"17344",title:"Towards New Anticancer Strategies by Targeting Cancer Stem Cells with Phytochemical Compounds",slug:"towards-new-anticancer-strategies-by-targeting-cancer-stem-cells-with-phytochemical-compounds",signatures:"Sharif Tanveer, Emhemmed Fathi and Fuhrmann Guy",authors:[{id:"32270",title:"Dr.",name:"Guy",middleName:null,surname:"Fuhrmann",fullName:"Guy Fuhrmann",slug:"guy-fuhrmann"},{id:"95078",title:"Mr.",name:"Fathi",middleName:null,surname:"Emhemmed",fullName:"Fathi Emhemmed",slug:"fathi-emhemmed"},{id:"95082",title:"Mr.",name:"Tanveer",middleName:null,surname:"Sharif",fullName:"Tanveer Sharif",slug:"tanveer-sharif"}]},{id:"17345",title:"Isolation of Liver Cancer Stem-Like Cells by Hoe33342 or Rhodamine123 Efflux",slug:"isolation-of-liver-cancer-stem-like-cells-by-hoe33342-or-rhodamine123-efflux",signatures:"Weihui Liu, Nan You and Kefeng Dou",authors:[{id:"29825",title:"Prof.",name:"Weihui",middleName:null,surname:"Liu",fullName:"Weihui Liu",slug:"weihui-liu"},{id:"38333",title:"Prof.",name:"Kefeng",middleName:null,surname:"Dou",fullName:"Kefeng Dou",slug:"kefeng-dou"},{id:"83386",title:"Dr.",name:"Nan",middleName:null,surname:"You",fullName:"Nan You",slug:"nan-you"}]},{id:"17346",title:"Large-Scale Production of Human Glioblastoma-Derived Cancer Stem Cell Tissue in Suspension Bioreactors to Facilitate the Development of Novel Oncolytic Therapeutics",slug:"large-scale-production-of-human-glioblastoma-derived-cancer-stem-cell-tissue-in-suspension-bioreacto",signatures:"Krishna Panchalingam, Wendy Paramchuk, Parvinder Hothi, Nameeta Shah, Leroy Hood, Greg Foltz and Leo A. Behie",authors:[{id:"32955",title:"Prof.",name:"Leo",middleName:"Augustus",surname:"Behie",fullName:"Leo Behie",slug:"leo-behie"}]},{id:"17347",title:"Cancer Stem Cells: The Role of the Environment and Methods to Identify Them",slug:"cancer-stem-cells-the-role-of-the-environment-and-methods-to-identify-them",signatures:"Giuseppe Pirozzi",authors:[{id:"34509",title:"Dr.",name:"Giuseppe",middleName:null,surname:"Pirozzi",fullName:"Giuseppe Pirozzi",slug:"giuseppe-pirozzi"}]},{id:"17348",title:"Modulation of Multidrug Resistance on the Same Single Cancer Cell in a Microfluidic Chip: Intended for Cancer Stem Cell Research",slug:"modulation-of-multidrug-resistance-on-the-same-single-cancer-cell-in-a-microfluidic-chip-intended-fo",signatures:"XiuJun Li, Yuchun Chen and Paul C.H. Li",authors:[{id:"29972",title:"Prof.",name:"Paul",middleName:null,surname:"Li",fullName:"Paul Li",slug:"paul-li"},{id:"40073",title:"Prof.",name:"XiuJun",middleName:null,surname:"Li",fullName:"XiuJun Li",slug:"xiujun-li"},{id:"40074",title:"Ms.",name:"Yuchun",middleName:null,surname:"Chen",fullName:"Yuchun Chen",slug:"yuchun-chen"}]},{id:"17349",title:"Evolution of Cancer Stem Cells",slug:"evolution-of-cancer-stem-cells",signatures:"Stanley Shostak",authors:[{id:"28104",title:"Prof.",name:"Stanley",middleName:null,surname:"Shostak",fullName:"Stanley Shostak",slug:"stanley-shostak"}]}]}]},onlineFirst:{chapter:{type:"chapter",id:"76038",title:"Endogenous Endophthalmitis: Etiology and Treatment",doi:"10.5772/intechopen.96766",slug:"endogenous-endophthalmitis-etiology-and-treatment",body:'Endophthalmitis is defined any infectious inflammation of vitreous, retina, or choroid that may or may not involve the anterior chamber. A useful classification is to define the infectious agent as exogenous or endogenous depending the route of infection. Exogenous endophthalmitis occurs from direct entry of pathogen(s) after disruption of ocular tissues, whether from trauma (like an open globe injury) or from surgical interventions (such as cataract or glaucoma surgery, intravitreal injection, or retinal surgery). Alternatively, endogenous endophthalmitis occurs when pathogens spread from other parts of the body to the eye (mainly by hematogenous spread but can also be neuronal in case of some viruses) with a subsequent compromise to the blood-ocular barrier. Since the choroid and the retina are highly vascularized, these structures may be seeded early in the systemic infection. In this chapter, we discuss endogenous endophthalmitis including the incidence, causes, and management of bacterial, viral, fungal, and other less common infectious agents.
While endogenous bacterial endophthalmitis comprises the minority (2–8%) of endophthalmitis cases, it is a devastating intraocular infection that often results in poor visual outcomes, loss of the eye, and even mortality [1, 2, 3, 4]. Nineteen percent of cases have a bilateral presentation [5]. Prompt recognition and treatment is vital for improved visual outcome. Unfortunately, many patients with EBE are either initially misdiagnosed (up to 25% of cases) or have a delay in diagnosis (a median of seven days) [2, 3, 4]. EBE is most commonly misdiagnosed as non-infectious uveitis but can also be mistaken for acute angle closure glaucoma, conjunctivitis, or orbital cellulitis [3, 4]. In children, EBE is most often misdiagnosed as retinoblastoma [3, 4].
Familiarity with common clinical features is crucial for proper diagnosis of EBE. Blurred vison (89%) and pain (48%) are common presentations, although they are not always present [3]. The most common systemic findings include fever (37%), often a low-grade fever and chills, and influenza-like features (20%) [3].
The absence of a clear view of the fundus is the most common ocular sign (40%), but other important exam findings include anterior chamber reaction (32%), hypopyon (35%), and vitritis (33%). Hypopyon color can be associated with different causative organisms. For example,
Endogenous bacterial endophthalmitis is also known as metastatic endophthalmitis, since an extraocular (systemic) focus of infection is typically the source. Liver abscesses are the most common sources of infection followed by lung and cardiac infections [3]. Other foci include soft tissue infection, meningitis, urinary tract infection (UTI), brain, and renal abscesses. Moreover, patients diagnosed with EBE often have underlying medical conditions that lead to an immunosuppressed state such as Diabetes mellitus (DM), Human Immunodeficiency Virus (HIV) infection, autoimmune disease, and malignancy [3, 4]. Other predisposing factors for EBE include high-risk behaviors such as IV drug use (IVDU) and alcohol abuse [3].
These infections are often life-threatening, so investigations into underlying foci and risk factors are paramount. In fact, mortality rates as high as 5% have been reported in patients with EBE from an extraocular infection [4]. Blood cultures remain the most reliable way to establish a diagnosis. These cultures are routinely performed in a hospital setting, and although they are more likely to identify the underlying pathogen compared to intraocular cultures, results can be negative in up to half of cases [3, 4, 5, 8, 9]. Intraocular cultures become very important in cases of negative blood cultures. They can be obtained from the anterior chamber by paracentesis (AC tap) or from vitreous collection, either by needle aspiration or during pars plana vitrectomy (PPV). Experimental and clinical studies of exogenous bacterial endophthalmitis have found vitreous cultures to have a higher yield compared to aqueous cultures [10, 11]. It is less clear whether these results apply to EBE eyes. Nevertheless, a review of 342 cases of EBE found anterior chamber samples obtained alongside vitrectomy to be positive in 21% of the cases while a positive vitreous sample was obtained during vitrectomy in 41% of the cases [3]. Yet, AC tap has been advocated to be performed in eyes with more prominent anterior chamber inflammation and when the offending microorganism is still unknown [12]. Moreover, AC tap is a less invasive procedure than vitreous sampling. Due to its high sensitivity, PCR has emerged as an adjunct to cultures in diagnosing EBE. It is capable of amplifying DNA from a single bacterium in a few hours. Hence, it can establish a diagnosis days before culture results become finalized and identify organisms in a culture-negative specimen, even after antibiotic treatment has been initiated [13, 14, 15, 16]. However, PCR has not replaced the utility of traditional cultures. It does not offer any insight into antibiotic sensitivity, which is important for antimicrobial stewardship, and its high sensitivity makes it vulnerable to false positive results from cross-contamination [17]. Nevertheless, due to increased affordability and reproducibility in addition to the aforementioned benefits, PCR is becoming increasingly utilized even in developing countries [18, 19, 20].
Regional variations exist regarding bacterial organisms that cause EBE. For example, Gram-positive bacteria comprise the majority of infections in North America and Europe, while Gram-negative organisms predominate in East Asia [1, 5]. This discrepancy can be attributed to
The most common Gram-positive bacteria in EBE are
Group B
Treatment of EBE has evolved significantly in the last century, particularly after the introduction of antimicrobial agents. Initially, systemic administration was common practice and is still necessary to save the patient’s life, but systemic therapy has lower efficacy of saving the eye. It has been established that antibiotic intraocular levels are insufficient to achieve any ocular clinical benefit [71, 72]. It is important to note that despite loss of vision, the infection in the eye should be treated to prevent meningitis and contiguous spread to the surrounding orbital tissues.
In the 1970s, Peyman et al. used animal models to better understand the blood-ocular barrier and to determine non-toxic doses of antimicrobials. They established the use of intravitreal antibiotic injections (IVI) as the standard of care for the treatment of endophthalmitis [73, 74, 75, 76]. In the 1990s, the Endophthalmitis Vitrectomy Study (EVS), which studied only exogenous endophthalmitis, established IVI (IVI- of Pharmaceuticals) as standard of care and reported no additional benefit for using systemic ceftazidime and amikacin [77]. Nevertheless, the studied population was post-operative endophthalmitis patients, so the results may not be directly applicable to patients with EBE [77]. Also, they used systemic steroids rather than intravitreal steroids, the latter of which are known to be beneficial in saving visual function by decreasing intraocular inflammatory mediators and the former are questionably prudent in a systemic infection.
Although the treatment of EBE remains controversial due to a paucity of clinical trials, systemic antibiotics remain essential, as many patients have an underlying systemic infection or a distal infectious focus. In fact, in a study that looked at 342 cases of EBE, the two patients who did not receive systemic antibiotics died, while the 51 patients who did receive appropriate systemic treatment survived, although this was not statistically significant (P = 0.10) [4]. Currently, systemic antibiotics are seldom used as a monotherapy but are often used in combination with intravitreal antibiotics, and sometimes PPV [3].
Selection of appropriate antimicrobial agents for IVI depends on several factors, including the patient’s allergies, the targeted organism, and antibiotic sensitivity and resistance. The most commonly used antimicrobials in IVI for empiric treatment are vancomycin for Gram-positive and ceftazidime for Gram-negative microorganisms [3]. Amikacin and gentamicin IVI can also be used for Gram-negative microorganisms [4]. A tap-and-inject technique is recommended: An intravitreal tap is initially performed through the pars plana to collect a sample of the vitreous for Gram staining and culture, followed by IVI.
Intravitreal corticosteroids have also been used to counter the inflammatory reaction associated with EBE. Dexamethasone is typically the agent of choice. It has been shown to be safe for all ocular structures up to 4 mg and may reduce the need for repeated antibiotic injections as well as improve visual outcomes [3, 25, 78].
The requirement for surgical intervention is not well established in the treatment of EBE. The EVS recommended PPV for patients with light perception vision, but as mentioned previously, the study involved patients with postoperative bacterial endophthalmitis only [77]. Nevertheless, there are several advantages of performing early vitrectomy on patients with EBE, including removing the infectious material from the vitreous and providing ample material for culture. A large series reported improved visual outcomes and lower rates of eviscerations and enucleation in a group of patients who received vitrectomy
Spirochetes are unique bacteria with distinct long helically coiled cells. Members of the phylum Spirochaetes include
The most common ocular manifestation of syphilis is generally agreed to be posterior uveitis followed by panuveitis, although some report granulomatous iridocyclitis as being most common [83, 86, 87]. Isolated intermediate and anterior uveitis can also occur [88]. Ocular syphilis can also present with necrotizing retinitis that can mimic acute retinal necrosis (ARN) or progressive outer retinal necrosis (PORN). However, these viral entities tend to progress quickly and are unresponsive to penicillin, whereas necrotizing retinitis secondary to syphilis tends to be slower and responsive to penicillin [89]. Moreover, retinal vasculitis can occur with occlusive manifestations [89, 90]. Patients with ocular syphilis may have several distinct retinal findings that could assist in diagnosis, such as creamy white preretinal precipitates that can migrate over time [91]. In addition, retinal lesions can heal with minimal retinal pigment epithelium involvement [23]. Acute syphilitic posterior placoid chorioretinitis is also a distinct and rare retinal manifestation of ocular syphilis characterized by discrete oval lesions of the outer retina and the inner choroid [83]. It is believed that these lesions occur secondary to inflammation from direct invasion of
One study examining 453 patients in an HIV clinic found incidence of syphilis to be 7.3%, of which 9% had ocular manifestations [94]. HIV-positive patients also showed higher rates of concurrent ocular syphilis at a younger age than immunocompetent patients [84, 88, 95]. Moreover, several studies have demonstrated that HIV-positive patients are more likely to have isolated anterior uveitis than HIV-negative patients [88, 96]. Therefore, the CDC recommends that all patients with HIV should be screened for syphilis, and all patients with syphilis should be screen for HIV. Screening for other common sexually transmitted diseases such as gonorrhea and chlamydia should also be performed. HIV-positive patients are more likely to present with acute, bilateral uveitis with more aggressive ocular involvement than HIV-negative patients [84, 85]. However, the CD4 count has not been shown to affect the frequency of ocular syphilis in HIV-positive patients [97].
Diagnosis of syphilis is achieved by nontreponemal and treponemal tests. Nontreponemal tests include Venereal Disease Research Lab (VDRL) and rapid plasma reagin (RPR) tests, which are commonly used for screening. These tests are sensitive but not specific; therefore, a positive result must be confirmed with a treponemal test such as fluorescent treponemal antibody absorption test (FTA-ABS),
Ocular syphilis is categorized as a subtype of neurosyphilis and should receive prompt treatment, as delay in treatment may result in visual loss. Only 12% of patients diagnosed with neurosyphilis were found to have ocular involvement, and syphilitic meningitis does not always accompany ocular syphilis [97, 100]. Nevertheless, the CDC recommends a lumbar puncture to be performed on all patients with syphilis and ocular complaints, even in the absence of clinical neurological findings. Commonly, CSF-VDRL is the initial test followed by CSF-FTA-ABS if the former test is positive [101].
The recommended treatment by CDC for ocular syphilis includes intravenous aqueous crystalline penicillin G, 18 to 24 million units per day administered as 3 to 4 million units every four hours or continuous infusion over 10 to 14 days. An alternative regimen, if patient compliance is guaranteed, is 2.4 million units of intramuscular procaine penicillin G once daily in addition to 500 mg oral probenecid four times a day, both for 10 to 14 days.
Leptospirosis, caused by the spirochete
The diagnosis of intraocular tuberculosis can be challenging, as it may have no pathognomonic eye findings. Instead, it has a protean presentation, which can appear similar to non-tubercular infections. Patients with HIV are more likely to develop intraocular TB than HIV-negative patients [3, 126]. However, severe intraocular TB can also occur in healthy individuals, which may cause a delay in diagnosis and treatment resulting in profound visual and organ loss [129, 130].
Uveitis is the most common ocular manifestation and can take the form of granulomatous anterior uveitis (12–36%), intermediate uveitis, posterior uveitis (11–20%) and most commonly, panuveitis (34–42%) [128]. Retinal manifestations can include multi-focal choroiditis, chorioretinitis, serpiginous-like choroiditis and choroidal tubercles [131, 132, 133, 134, 135, 136]. Ocular tuberculosis can even be severe enough to cause panophthalmitis [137].
Identifying
Together, these factors make accurate diagnosis of intraocular TB challenging. Nevertheless, certain ophthalmic findings can increase the likelihood of establishing the correct diagnosis. A study found that broad-based posterior synechiae, retinal vasculitis with or without choroiditis, and serpiginous-like choroiditis demonstrate a high likelihood of intraocular TB being present; however, the absence of these signs does not rule out the disease [143]. Moreover, retinal vasculitis in intraocular TB mainly involves the veins with perivascular cuffing and vitritis, and focal choroiditis lesions tend to be under the vessels [131, 144]. A presumed intraocular TB diagnosis can be made when these signs are present in addition to a positive tuberculosis test such as Tuberculin Skin Test (TST), QuantiFERON-TB Gold, chest radiograph, or computed tomography of the chest.
Being aware of the limitations of each diagnostic test is vital. As mentioned previously, TST can produce false negative results in some patients. These patients typically have anergy as result of immunosuppression or disseminated TB, hence TST should not be used to rule out TB when suspicion is high [145]. Moreover, spiral chest computed tomography is more sensitive in the detection of pulmonary TB and should be used in cases with normal radiography and high suspicion of the disease [146]. PPV can be an important diagnostic and therapeutic intervention, as it was found to have a higher yield than vitreous tap in returning positive for mycobacteria (87.5% vs. 14.3%, respectively) [142]. Moreover, PPV may have a similar role in improving visual outcomes and reducing the possibility of enucleation in intraocular TB as was demonstrated in EBE cases. PCR also has a high diagnostic value and can be more accurate than cultures in diagnosing intraocular TB [142].
In the absence of confirmatory tests such as direct visualization of the mycobacteria, positive response to antitubercular therapy (ATT) supports the diagnosis of presumed intraocular tuberculosis. In fact, any delay in treatment to establish a definitive diagnosis is discouraged. One study found that systemic antibiotics were started in 47.6% of endophthalmitis of unknown etiology cases prior to establishing a definitive diagnosis [142]. Antitubercular therapy comprises a four-drug regimen: isoniazid, rifampicin, ethambutol, and pyrazinamide. The role of steroids as part of ATT remains controversial. Some studies have found that steroids can be effective in reducing TB-associated mortality and recurrences of uveitis as well as treating macular edema [141, 147], while another multi-center study found the use of steroids was associated with higher treatment failure rates [148]. Failure rates were higher when steroid treatment was started prior to initiation of ATT compared to after [148]. Therefore, judicious use of steroids is recommended as part of ATT. In fact, there might be two different pathophysiological mechanisms behind the intraocular inflammation: an active mycobacterial infection of the eye and an immunological response to the pathogen located elsewhere in the body [3, 143]. Thus, steroids may be more beneficial in the latter case. Higher treatment failure rates were also observed in patients with choroidal involvement and associated vitreous haze [148]. Caution and close observation of patients on ATT is required as isoniazid and ethambutol can cause toxic optic neuropathy [149]. Nevertheless, TB-associated endophthalmitis has a very poor outcome. The majority of cases (83.7%) end in either evisceration, enucleation or exenteration of the eye [142]. Of note, this figure is significantly higher than for EBE which is reported to be 20% [3].
Nontuberculous mycobacteria (NTM) have also been shown to cause endogenous endophthalmitis [150]. They can be divided into slow and rapid growers [151]. The latter group comprises the most cases of overall ocular infections and carries worse visual outcomes [152, 153]. However, rapid growers are mainly associated with exogenous endophthalmitis and can occur in healthy individuals [150]. On the other hand, endogenous endophthalmitis is typically secondary to infection by slow growers and occurs almost exclusively in immunocompromised patients. The source of infection is often unknown but disseminated infections have been documented [150, 154]. Some of the NTM slow growers implicated in endogenous endophthalmitis include
Viral infections represent a significant cause of posterior segment endogenous endophthalmitis due to their systemic spread, and viruses are more likely than other organisms to spread via a neuronal pathway. Viral infections can appear as isolated ocular manifestations or as part of a systemic infection. For example, Herpes Simplex virus 1 (HSV-1) and Varicella Zoster virus (VZV) spread via transaxonal route while Cytomegalovirus (CMV) and Epstein Barr virus (EBV) spread via hematogenous route within lymphocytes [159]. Infections causing posterior segment infections can lead to manifestations of the choroid, retina, and vitreous due to their highly vascularized nature [160, 161]. Prompt recognition and treatment can lead to improved visual outcomes in patients, but EVE is often misdiagnosed as non-infectious uveitis, anterior uveitis, or conjunctivitis, leading to poorer outcomes [160].
Patients with EVE often have an underlying immunosuppressed condition, so they should be evaluated for underlying immunosuppression if not already known [65]. DM, corticosteroid use, diminished lymphocyte response, HIV/AIDS, and malignancy can all encourage viruses to proliferate [162]. Patients with a history of travel to endemic areas or close contact with farm animals (particularly swine herders) should be evaluated for EVE [161]. Cases of EVE following systemic Ebola and COVID-19 infections have also been documented [163, 164]. There have been cases of viral endophthalmitis following intravitreal steroid injections that are exogenous in nature [160]. Identifying the common clinical features can aid in the prompt diagnosis of EVE. Common features include photophobia, decreased visual acuity, and eye pain [161]. Other presenting ocular features include conjunctival hemorrhages, peripapillary hemorrhage, narrowing of the inferior retinal vessels, anterior segment inflammation, focal lesion of the posterior pole, vitreous inflammation, occlusive vasculitis, keratic precipitates, chorioretinal scarring, ocular hypertension, and neovascularization [160, 163, 164]. EVE frequently presents as unilateral disease on presentation but can become bilateral as it progresses [160, 165, 166, 167].
Successful treatment of EVE requires prompt diagnosis using fluid from a vitreous tap [160]. PCR is the main laboratory test that has been effective in establishing diagnosis of viral infection such as HSV, VZV and CMV [160]. One study examined aqueous and vitreous fluid samples for HSV-1, HSV-2, VZV, EBV, CMV, and Human Herpesvirus 6 found PCR to have sensitivity and specificity of 91.3% and 98.8%, respectively in detection of herpes viruses as well as toxoplasma and fungal elements [168]. Viral serology of the vitreous is effective in confirming the pathogen involved in 80–90% of cases [160, 169, 170] and frequently changes the working diagnosis (23%) or confirms an uncertain diagnosis (39%) [170]. Moreover, PCR sensitivity can be further improved when combined with the calculation of Goldmann-Witmer coefficient (GWC) and immunoblotting for ocular fluid and serum antibodies. The GWC is a comparison of specific antibodies levels to total immunoglobulin in both aqueous humor and serum samples. Multiplex PCR allows testing of several organisms from a single ocular sample; however, this process, similar to monoplex PCR, does require the knowledge of a particular virion’s sequence information prior to testing in order to design the primer necessary to generate a PCR product [171]. Fundus photography, retinal imaging, and optical coherence tomography (OCT) are all useful in diagnosing and monitoring EVE [160, 172].
Treatment of EVE requires systemic antivirals, intravitreal antivirals (or intraocular antiviral implants), and systemic corticosteroids for inflammation [160]. In the 1990s, Peyman and many others noted improvement of cytomegalovirus (CMV) retinitis after treatment with intravitreal ganciclovir and systemic antivirals [76, 173, 174, 175, 176, 177, 178, 179]. Studies also confirm the efficacy of systemic valaciclovir for appropriate management of EVE [179]. The role of systemic and intravitreal acyclovir for treatment of herpes virus retinitis has also been documented [174, 178]. Management of both ocular and systemic complications is essential for a favorable prognosis [160]. Long-term preventative antiviral therapy may be considered if patients present with recurrent inflammation. Patients may require anti-vascular endothelial growth factor agents for macular edema or neovascularization [160] and may also undergo vitrectomy for proper management. Vitrectomy should be considered when patients present with severe inflammation, retinal detachment, or traction that may create a detachment. Vitrectomy with silicone-oil tamponade and scleral buckle placement has been proven successful [179]. Caution should be taken in eyes of patients with a history of Ebola virus disease who present with evolving dark retinal regions, as these are characteristic of viable
Several viruses have been implicated in the development of EVE. Most commonly, it is due to reactivation of the herpesvirus family, specifically varicella zoster virus (VZV), herpes simplex virus (HSV I and HSV II), CMV, and Epstein–Barr virus (EBV) [160, 180, 181]. The outcome of viral reactivation is influenced by multiple factors including strain virulence, human leukocyte antigen, and host immune response. HSV- EVE is generally well treated with systemic antiviral and corticosteroids with the resolution of symptoms [181]. However, as the virus remains latent in the trigeminal and dorsal root ganglion, recurrence is possible [181]. VZV-EVE may occur in adults with chickenpox but is rare in children [160]. It is more common in adults and may precede shingles in immunocompromised patients, but Acute Retinal Necrosis (ARN) can occur in patients with normal immune function; HSV I, HSV II, and VZV can cause ARN [182]. VZV generally has a poorer prognosis compared to HSV. EBV-EVE generally has a good prognosis and resolves rapidly with near-complete recovery [160]. Most people (90%) are CMV seropositive (it is thought to be latent in bone marrow) so it periodically actively replicates in both immunocompromised and normal patients. Therefore, culture of CMV shed in the patient’s urine does not mean active systemic CMV infection to support the diagnosis of CMV retinitis. Patients can experience systemic symptoms, but ocular manifestations are more likely to be the initial finding [183]. CMV retinitis has historically had poor visual outcomes, although new antiretroviral therapies have decreased its incidence and improved outcomes [183]. Patients may experience reactivation of herpesvirus infections following other viral infections, such as COVID-19 [184].
Other causes implicated with EVE include pseudorabies, Zika virus, Dengue, Ebola, Chikungunya, and COVID-19 [163, 164, 165, 185]. Unlike herpesvirus infections, patients typically do not present with a history of immunosuppression. However, history is significant with respect to travel to endemic areas or known exposure to infected individuals [163, 164, 165, 185]. The posterior vitreous cavity may act as a reservoir for some viral infections. Zika and COVID-19 infections are notable for the presence of viral RNA in the tears [165]. In contrast, patients with Ebola Virus Disease (EBD) in the eye are negative for Ebola of the tears and conjunctiva [163]. However, virions have been recovered from the anterior chamber in eyes of recovered Ebola patients and poses a risk for cataract surgeons [163].
Patients with ocular viral infections are also at risk for reactivation of other bacterial or fungal agents in the eye. Cases of toxoplasmosis following Ebola infection have been documented in a small subset of patients [127]. Compared to more common causes, novel causes of EVE (Dengue and COVID) have no prospective, randomized therapeutic trials. As such, definitive therapies are not well established, and prognosis can range from full resolution to permanent vision loss [165, 185]. COVID-19 and Zika are more likely to cause poor visual outcomes compared to standard causes [164, 165]. Prompt diagnosis and early treatment are important for good visual outcomes of EVE.
Fungi can lead to infection of the posterior chamber through hematogenous spread; in fact, this represents the most frequent cause of EFE [186, 187]. Most cases of fungal endogenous endophthalmitis have a predisposing systemic risk factor. Common risk factors for EFE include recent hospitalization, systemic surgery, indwelling catheter, broad-spectrum antibiotic use, steroids, parenteral nutrition, cytotoxic therapies, and gastrointestinal disease [186]. Lower abdominal procedures, including genitourinary procedures (e.g. uterine curettage, urinary tract dilation, lithiasis removal), and toe-nail extraction due advanced onychomycosis have been implicated with EFE [188]. Most cases of fungal endogenous endophthalmitis have a predisposing systemic risk factor [189]. Diagnosis of EFE is frequently missed, as these characteristic findings might mimic non-infectious uveitis and orbital cellulitis [190]. In the pediatric population, common misdiagnoses are orbital cellulitis, congenital glaucoma, conjunctivitis, and retinoblastoma [191]. Misdiagnosis rates range from 16% to 63% [4, 191].
Patients who experience misdiagnosis can experience a delay in diagnosis (mean of 13 days) [186, 192], but familiarity with the clinical features of EFE can aid in avoiding this. Patients frequently complain of blurry or decreased vision (77%), redness (49%), eye pain (34%), floaters (26%), and photophobia (12%) [192]. Systemic symptoms also include frequently mild and relapsing fever, scalp lesions, and other pain [193]. In a study that examined 65 eyes with EFE found most eyes to have diffuse anterior and posterior segment inflammation (71%), followed by focal posterior inflammation (28%) and focal anterior segment inflammation (2%) [186]. Eyes with EFE can have some characteristic exam findings that can help in establishing a proper diagnosis. For example, eyes with EFE from
Due to their systemic nature in immunocompromised patients, cases are more likely to be bilateral compared to other causes of endogenous endophthalmitis, but the majority are still unilateral [196]. Unlike bacterial causes, EFE is less associated with a known focal systemic lesion. About 44% of patients with EFE from
An accurate diagnosis of the causative agent is essential to the treatment of EFE. Culture positivity for
The
Pathogenic dimorphic fungi have also been implicated in EFE. Unlike opportunistic causes, pathogenic dimorphic fungi are usually regionally restricted. These infections can cause endophthalmitis in both immunocompetent and immunocompromised hosts. EFE is primarily a result of a disseminated pulmonary infection [196, 206]. Examination of the eye for dimorphic fungi shows fluffy yellow/white aggregates with retinal hemorrhages.
Treatment of endogenous fungal endophthalmitis in the eyes of pediatric population have shown favorable resolution with systemic and intravitreal antifungals, intravitreal steroids, and early surgical intervention. However, there is no specific guideline for dosing of pediatric patients with EFE with systemic and intravitreal antibiotics. [192]. While patients with EFE have shown resolution of symptoms, as noted, with systemic and intravitreal antifungal medications, eyes that present with poor vision or are refractory to injected antifungals should undergo vitrectomy [198]. Surgical intervention via early PPV has been proven to have therapeutic efficacy [199].
Of all the fungal causes, infections with
Protozoans, unicellular eukaryotic organisms, are a major cause of intraocular infections worldwide. Different protozoa have special animal hosts with varying routes of infection. Travel and dietary history as well as patient habits are important in establishing a diagnosis, since most transmission occurs through contaminated food and water sources in endemic areas. Protozoa such as
Other clinical classifications of toxoplasmosis include acquired cases in immunocompetent and immunocompromised patients. Toxoplasmosis is mainly asymptomatic in healthy patients. Painless cervical lymphadenopathy is the main clinical manifestation if symptoms do occur. Retinochoroiditis is also a common feature, since
Retinochoroiditis is frequently subclinical but can result in retinal detachment and loss of vision [228, 234]. Other symptoms may include pain, photophobia and epiphora. Ophthalmic exam is vital in the diagnosis of retinochoroiditis, which typically presents as a focal white lesion with overlying vitritis. When vitritis is severe, a classic finding of “headlight in the fog” can be seen. Healed lesions become atrophic and develop a scar bordered with black pigment. Atypical lesions found in elderly and immunocompromised patients have distinctive characteristics including hemorrhages, multiple foci and features present in acute retinal necrosis (ARN) such as peripheral retinitis, vasculitis and vitritis [235, 236]. Early management of toxoplasmosis in immunodeficient patients is vital, as disseminated disease has 100% mortality if left untreated.
Recurrences of retinochoroiditis are common, roughly 80%, with a median interval of two years [237]. New lesions tend to occur at the border of an old, scarred lesion. Recurrences are more common after cataract extraction and in patients older than 40 years of age as well as in previously affected eyes [237, 238, 239]. Nevertheless, late sequelae and recurrences from congenital infection tend to be bilateral, more severe, and involve the macula, whereas acquired infections are usually unilateral, spare the macula, and are not associated with an old chorioretinal scar [228, 232, 240].
The diagnosis of toxoplasmosis is mainly clinical based on characteristic retinal lesions; however, serology can confirm the exposure to the protozoa. Various methods exist for detecting IgG and IgM immunoglobulins against
These serological tests only reveal previous exposure to
There is a lack of evidence supporting the utility of routine antibiotic and steroid regimens in the treatment of acute retinochoroiditis [249]. Not all cases necessarily warrant treatment; for example, small lesions in the periphery that are not vision-threatening tend to be self-limited and will heal spontaneously in immunocompetent patients [250, 251, 252]. Most clinicians will treat patients with disease persisting more than one month and associated with reduced visual acuity. Other indications for treatment include lesions that are vision-threatening such as those affecting the macula or the optic nerve, lesions larger than one disc diameter, lesions in monocular patients, presence of multiple lesions, lesions associated with moderate to severe vitritis, active lesions over a large vessel, or lesions in immunocompromised patients [253]. The classic triple therapy comprises oral pyrimethamine, sulfadiazine, and prednisolone. Pyrimethamine is prescribed with folinic acid to prevent bone marrow toxicity (anemia). Alternative treatments include oral trimethoprim-sulfamethoxazole (TMP-SMX), azithromycin, or clindamycin, all of which have shown favorable results [254, 255, 256]. Intravitreal treatment has also been studied for the treatment of ocular toxoplasmosis [257, 258]. Combined clindamycin and dexamethasone intravitreal injections were found to be comparable to a regimen of oral pyrimethamine and sulfadiazine [258, 259, 260]. Intravitreal TMP-SMX with dexamethasone also demonstrated benefit [261, 262]. Intravitreal injections can be favorable in pregnant patients due to their reduced systemic toxicity compared to oral medication [263, 264]. Photocoagulation around the foci of the scars and vitrectomy have also been performed; however, these studies are limited and did not show any preventive effect [265]. Fulminant ocular toxoplasmosis may occur with corticosteroid monotherapy, in which case vitrectomy may be warranted [266].
Helminths at either the larval or adult stage can lead to the infection of ocular tissues through adjacent structures or may have a predilection for ocular tissue as they migrate through the vascular system [267]. Helminths generally only have a unilateral eye presentation, but there is no observed difference in eye predominance [192]. Although infrequent, helminth infections are more common in areas of consumption of contaminated water, raw meat, and freshwater fish [268, 269], so travel history to endemic areas is essential to ascertain the source of the infection. However, due to movement via rapid transport, such history might not be present [267]. Helminth endogenous endophthalmitis is much less frequent compared to bacterial, viral, and fungal causes. Pediatric populations are more likely to have zoonotic infections, such as
Due to the nature of these parasites, pathological lesions show a wider variety of clinical presentations compared to other causes of EE. Perhaps the most common cause of helminth infection is
Two helminths with ocular manifestations are
One helminth unique to the pediatric population is
The most common helminths in the pediatric population are
Helminths have also shown surprising manifestations in immunocompromised hosts. One patient with a history of systemic lupus erythematosus (SLE) presented with decreased bilateral vision in both eyes. Fundoscopy showed granulomas in the posterior poles bilaterally, with new granulomas developing in subsequent exams. Serology was positive for
Another subset of immunocompromised patients who are at risk for helminth-induced endogenous endophthalmitis is the IVDU population. One patient with a history of IVDU reported two weeks of worsening right eye pain with decreased visual acuity. Endophthalmitis was suspected and a vitreous tap was performed. Gram stain showed no organisms, but rare white blood cells were present. Initial labs, bacterial and fungal cultures were negative. The patient was admitted for the endogenous spread of infection and placed on IV antibiotics. The patient’s repeat serology was found to be positive for
Diagnosis of
Immunocompromised patients with significant animal contact who present with suspicion of endogenous endophthalmitis should be considered for a helminth cause [4, 9]. Treatment of ocular toxocariasis should be tailored to the clinical presentation of the host, and patients with inflammation should be placed on steroids to reduce the risk of retinal detachment. Anti-helminthic agents and IV antibiotics have been successful, but surgical intervention may be necessary if complications occur [280].
Endogenous endophthalmitis can be a result of a systemic infection from a myriad of infectious agents including bacteria, viruses, fungi, protozoa, and helminthic organisms. Systemic infection should be suspected when there is no history of surgical intervention or trauma. Unlike exogenous endophthalmitis, the onset of clinical manifestations may be insidious and difficult to diagnose. This is particularly true in nonverbal patients.
Clinical presentations may be bilateral or unilateral. Vitreous and retinal involvement are potentially sight threatening and appropriate investigations should be performed to find the distal infection focus or systemic source(s) of the endogenous endophthalmitis and treatment usually involves systemic agents aimed at the offending organism as well as intravitreal pharmacotherapy and/or pars plana vitrectomy (PPV) to both obtain a microbiological sample both to identify the organism and to therapeutically debride the vitreous cavity of the organism, inflammatory cells, and destructive cytokines. Occasionally a chorioretinal biopsy may be required to identify the organism. Despite aggressive treatment, the eye (s) may lose vision, and some may require enucleation.
Addendum Treatment (Tables 1–7) [281].
Amikacin 200 | |
---|---|
Ceftazidime 2.2 mg/0.1 ml | Step 1: Reconstitue 1000 mg ceftazidime powder with 8 ml of 0.9% NaCl for injection USP (Preservative Free) |
Step 2: Withdraw all 8 mL of that the solution prepared in step 1 and add saline to create total volume of 10 ml. Then, withdraw 1 ml of that solution in a second syringe with 3.5 ml of 0.9% NaCl for injection USP (Preservative Free) (Total volume 4.5 mL) | |
Step 3: Withdraw 0.1 from the step 2 solution (22.2 mg/ml), which will now contain 2.2 mg/0.1 ml of ceftazidime | |
Clindamycin 450 | Step 1: Withdraw 0.3 ml from a vial of clindamycin (150 mg/ml) |
Step 2: Add the step 1 solution to a second 10 ml syringe containing 9.7 ml of 0.9% NaCl for injection USP (Preservative Free) | |
Step 3: Withdraw 0.1 ml from step 2 solution (4.5 mg/ml), which will now contain 450 | |
Gentamicin 100 | Step 1: Withdraw 0.25 ml (10 mg) from a gentamicin vial (40 mg/ml) |
Step 2: Add the above 0.25 ml to a new 10 ml syringe containing 9.75 ml of 0.9% NaCl for injection USP (Preservative Free) (Final concentration 1mg/ml) | |
Step 3: Withdraw 0.1 from step 2 solution (1 mg/ml), which will now contain 100 | |
Vancomyci 1 mg/0.1 ml | Step 1: Dilute a vial of vancomycin powder (500 mg) with 10 ml 0.9% NaCI for injection USP (Preservative Free) Final concentration (50 mg/ml) |
Step 2: Withdraw 1 ml solution prepared in step 1 (50 mg/ml) into a new 5 ml syringe and add 4 ml of 0.9% NaCl for injection USP (Preservative Free) Final concentration (10 mg/ml) | |
Step 3: Withdraw 0.1 from the step 2 solution (10 mg/ml), which will now contain 1 mg/0.1 ml of vancomycin | |
Dexamethasone 1000 | Step 1: Withdraw 0.1 ml from a dexamethasone vial up containing 10 mg/ml vial |
Amphotericin B 5 | Step 1: one vial of 50 mg amphotericin B is diluted with 10 ml of sterile water (Preservative Free) Final concentration (5 mg/ml = 0.5 mg/0.1 ml) |
Step 2: Withdraw 0.1 ml of step 1 solution (0.5 mg/0.1 ml) and add it to 9.9 ml of sterile water (Preservative Free) Final concentration (0.05 mg/ml) | |
Step 3: Withdraw 0.1 ml from step 2 solution, which will now contain 5 |
Preparation of intravitreal pharmaceuticals.
Pearl 2: Avoid attaching antibiotics to the original vitreous biopsy needle while in the eye due to increased risk of retinal injury. It is preferred to withdraw the biopsy needle and re-enter the eye with a new needle for antibiotic delivery. Pearl 3: Injection of drugs should be limited to the smallest possible volume and the bevel of the needle should be placed toward the lens, not toward the retina w. Pearl 4: Do not combine dexamethasone and vancomycin in the syringe due to precipitation, but aminoglycosides and dexamethasone can be used in the same syringe. Of note, hemorrhagic occlusive retinal vasculitis has been reported with intravitreal gentamicin treatment |
Vitreous tap technique [265].
|
Pars Plana vitrectomy role Endophthalmitis [265].
Pearl 2: Vitrector can be safely placed behind the IOL in pseudophakic eyes. Pearl 3: We recommend intravitreal and systemic therapy in endogenous endophthalmitis cases, especially in mycotic cases. Pearl 4: Fluconazole 200 Pearl 5: -Vitreous tap should be performed initially followed by intravitreal injection of one-quarter the recommended antibiotic dose for non-vitrectomized eye along with 1 mg dexamethasone. -When purulent exudates are present in the vitreous cavity, we recommend the removal of silicone while using infusion fluid with recommended doses of antibiotics and steroids. -The recommended infusion fluid composition for EBE: 20 -Silicone oil can be injected immediately after removal of infected eye’s silicone oil or when inflammation is controlled. Pearl 6: We recommend the reduced antibiotic dosage (25%) for retreatment in all vitrectomized eyes. |
Pars Plana vitrectomy technique [265].
Pearl 2: Place the tissue specimen in the culture or fixation solution of choice and then promptly send it for microbiology and histology. Pearl 3: Minimize any trauma to the biopsy during the procedure and transport. Pearl 4: Often no further laser treatment or cryotherapy is required at the biopsy site. Pearl 5: Instruct the patient to lay on the appropriate side to tamponade the site with gas during sleep. Pearl 6: Closely follow up patients for any signs of retinal detachment. |
Chorioretinal biopsy technique.
Infusion Fluid Upper limit of drug dosages without toxicity in non-vitrectomized eyes* | |
---|---|
Drug | Nontoxic Dose (μg/ml) |
Single Drugs | |
Amikacin | 10 |
Amphotericin B methyl ester | 75 |
Ceftazidime | 40 |
Chloramphenicol | 10 |
Clindamycin | 9 |
Fluconazole | 200 |
Gentamicin | 8 |
Imipenem | 16 |
Lincomycin | 10 |
Methicillin | 20 |
Netilmicin | 4 |
Oxacillin | 10 |
Penicillin | 80 |
Teicoplanin | 8 |
Tobramycin | 10 |
Vancomycin | 20 |
Dexamethasone | 64 |
Combination Drugs | |
Clindamycin/Gentamicin | 9 / 8 |
Gentamicin/Oxacillin | 8 / 10 |
Methicillin/Gentamicin | 20 / 8 |
Penicillin/Gentamicin | 80 / 8 |
* |
Antibiotics in the infusion fluid for pars Plana vitrectomy.
Causative agents of endogenous endophthalmitis discussed in this chapter |
Gram-Positive Bacteria |
Group B Streptococcus and other Streptococcus species |
Nocardia species |
Gram-Negative Bacteria |
Neisseria meningitidis |
Salmonella species |
Serratia marcescens |
Viruses |
Cytomegalovirus |
Ebola virus |
Epstein–Barr virus |
Herpes Simplex virus |
SARS-CoV-2 |
Varicella-zoster virus |
Zika virus |
Protozoa |
Toxoplasmosis gondii |
Spirochetes |
Borrelia burgdorferi |
Leptospira |
Treponema pallidum |
Mycobacterium |
Mycobacterium kansasii |
Mycobacterium triplex |
Mycobacterium chelonae |
Mycobacterium bovis |
Causative agents of endogenous endophthalmitis discussed in this chapter.
Citation: Gholam A. Peyman, Stephen A. Meffert, Mandi D. Conway. Vitreoretinal Surgical Techniques, Second Edition, 2007.
"Open access contributes to scientific excellence and integrity. It opens up research results to wider analysis. It allows research results to be reused for new discoveries. And it enables the multi-disciplinary research that is needed to solve global 21st century problems. Open access connects science with society. It allows the public to engage with research. To go behind the headlines. And look at the scientific evidence. And it enables policy makers to draw on innovative solutions to societal challenges".
\n\nCarlos Moedas, the European Commissioner for Research Science and Innovation at the STM Annual Frankfurt Conference, October 2016.
",metaTitle:"About Open Access",metaDescription:"Open access contributes to scientific excellence and integrity. It opens up research results to wider analysis. It allows research results to be reused for new discoveries. And it enables the multi-disciplinary research that is needed to solve global 21st century problems. Open access connects science with society. It allows the public to engage with research. To go behind the headlines. And look at the scientific evidence. And it enables policy makers to draw on innovative solutions to societal challenges.\n\nCarlos Moedas, the European Commissioner for Research Science and Innovation at the STM Annual Frankfurt Conference, October 2016.",metaKeywords:null,canonicalURL:"about-open-access",contentRaw:'[{"type":"htmlEditorComponent","content":"The Open Access publishing movement started in the early 2000s when academic leaders from around the world participated in the formation of the Budapest Initiative. They developed recommendations for an Open Access publishing process, “which has worked for the past decade to provide the public with unrestricted, free access to scholarly research—much of which is publicly funded. Making the research publicly available to everyone—free of charge and without most copyright and licensing restrictions—will accelerate scientific research efforts and allow authors to reach a larger number of readers” (reference: http://www.budapestopenaccessinitiative.org)
\\n\\nIntechOpen’s co-founders, both scientists themselves, created the company while undertaking research in robotics at Vienna University. Their goal was to spread research freely “for scientists, by scientists’ to the rest of the world via the Open Access publishing model. The company soon became a signatory of the Budapest Initiative, which currently has more than 1000 supporting organizations worldwide, ranging from universities to funders.
\\n\\nAt IntechOpen today, we are still as committed to working with organizations and people who care about scientific discovery, to putting the academic needs of the scientific community first, and to providing an Open Access environment where scientists can maximize their contribution to scientific advancement. By opening up access to the world’s scientific research articles and book chapters, we aim to facilitate greater opportunity for collaboration, scientific discovery and progress. We subscribe wholeheartedly to the Open Access definition:
\\n\\n“By “open access” to [peer-reviewed research literature], we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited” (reference: http://www.budapestopenaccessinitiative.org)
\\n\\nOAI-PMH
\\n\\nAs a firm believer in the wider dissemination of knowledge, IntechOpen supports the Open Access Initiative Protocol for Metadata Harvesting (OAI-PMH Version 2.0). Read more
\\n\\nLicense
\\n\\nBook chapters published in edited volumes are distributed under the Creative Commons Attribution 3.0 Unported License (CC BY 3.0). IntechOpen upholds a very flexible Copyright Policy. There is no copyright transfer to the publisher and Authors retain exclusive copyright to their work. All Monographs/Compacts are distributed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Read more
\\n\\nPeer Review Policies
\\n\\nAll scientific works are Peer Reviewed prior to publishing. Read more
\\n\\nOA Publishing Fees
\\n\\nThe Open Access publishing model employed by IntechOpen eliminates subscription charges and pay-per-view fees, enabling readers to access research at no cost. In order to sustain operations and keep our publications freely accessible we levy an Open Access Publishing Fee for manuscripts, which helps us cover the costs of editorial work and the production of books. Read more
\\n\\nDigital Archiving Policy
\\n\\nIntechOpen is committed to ensuring the long-term preservation and the availability of all scholarly research we publish. We employ a variety of means to enable us to deliver on our commitments to the scientific community. Apart from preservation by the Croatian National Library (for publications prior to April 18, 2018) and the British Library (for publications after April 18, 2018), our entire catalogue is preserved in the CLOCKSS archive.
\\n"}]'},components:[{type:"htmlEditorComponent",content:'The Open Access publishing movement started in the early 2000s when academic leaders from around the world participated in the formation of the Budapest Initiative. They developed recommendations for an Open Access publishing process, “which has worked for the past decade to provide the public with unrestricted, free access to scholarly research—much of which is publicly funded. Making the research publicly available to everyone—free of charge and without most copyright and licensing restrictions—will accelerate scientific research efforts and allow authors to reach a larger number of readers” (reference: http://www.budapestopenaccessinitiative.org)
\n\nIntechOpen’s co-founders, both scientists themselves, created the company while undertaking research in robotics at Vienna University. Their goal was to spread research freely “for scientists, by scientists’ to the rest of the world via the Open Access publishing model. The company soon became a signatory of the Budapest Initiative, which currently has more than 1000 supporting organizations worldwide, ranging from universities to funders.
\n\nAt IntechOpen today, we are still as committed to working with organizations and people who care about scientific discovery, to putting the academic needs of the scientific community first, and to providing an Open Access environment where scientists can maximize their contribution to scientific advancement. By opening up access to the world’s scientific research articles and book chapters, we aim to facilitate greater opportunity for collaboration, scientific discovery and progress. We subscribe wholeheartedly to the Open Access definition:
\n\n“By “open access” to [peer-reviewed research literature], we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited” (reference: http://www.budapestopenaccessinitiative.org)
\n\nOAI-PMH
\n\nAs a firm believer in the wider dissemination of knowledge, IntechOpen supports the Open Access Initiative Protocol for Metadata Harvesting (OAI-PMH Version 2.0). Read more
\n\nLicense
\n\nBook chapters published in edited volumes are distributed under the Creative Commons Attribution 3.0 Unported License (CC BY 3.0). IntechOpen upholds a very flexible Copyright Policy. There is no copyright transfer to the publisher and Authors retain exclusive copyright to their work. All Monographs/Compacts are distributed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Read more
\n\nPeer Review Policies
\n\nAll scientific works are Peer Reviewed prior to publishing. Read more
\n\nOA Publishing Fees
\n\nThe Open Access publishing model employed by IntechOpen eliminates subscription charges and pay-per-view fees, enabling readers to access research at no cost. In order to sustain operations and keep our publications freely accessible we levy an Open Access Publishing Fee for manuscripts, which helps us cover the costs of editorial work and the production of books. Read more
\n\nDigital Archiving Policy
\n\nIntechOpen is committed to ensuring the long-term preservation and the availability of all scholarly research we publish. We employ a variety of means to enable us to deliver on our commitments to the scientific community. Apart from preservation by the Croatian National Library (for publications prior to April 18, 2018) and the British Library (for publications after April 18, 2018), our entire catalogue is preserved in the CLOCKSS archive.
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5816},{group:"region",caption:"Middle and South America",value:2,count:5281},{group:"region",caption:"Africa",value:3,count:1754},{group:"region",caption:"Asia",value:4,count:10511},{group:"region",caption:"Australia and Oceania",value:5,count:906},{group:"region",caption:"Europe",value:6,count:15912}],offset:12,limit:12,total:119060},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{sort:"dateEndThirdStepPublish",topicId:"11"},books:[{type:"book",id:"10689",title:"Risk Management in Construction",subtitle:null,isOpenForSubmission:!0,hash:"e3805b3d2fceb9d33e1fa805687cd296",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10689.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10679",title:"Mass Production",subtitle:null,isOpenForSubmission:!0,hash:"2dae91102099b1a07be1a36a68852829",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10679.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10826",title:"Artificial Muscles",subtitle:null,isOpenForSubmission:!0,hash:"2f86f1caeed80b392ec14ecd61def8e7",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10826.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10567",title:"Uncertainty Management in Engineering - Topics in Pollution Prevention and Controls",subtitle:null,isOpenForSubmission:!0,hash:"4990db602d31f1848c590dbfe97b6409",slug:null,bookSignature:"Prof. Rehab O. Abdel Rahman and Dr. Yung-Tse Hung",coverURL:"https://cdn.intechopen.com/books/images_new/10567.jpg",editedByType:null,editors:[{id:"92718",title:"Prof.",name:"Rehab",surname:"Abdel Rahman",slug:"rehab-abdel-rahman",fullName:"Rehab Abdel Rahman"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10568",title:"Hysteresis in Engineering",subtitle:null,isOpenForSubmission:!0,hash:"6482387993b3cebffafe856a916c44ce",slug:null,bookSignature:"Dr. Giuseppe Viola",coverURL:"https://cdn.intechopen.com/books/images_new/10568.jpg",editedByType:null,editors:[{id:"173586",title:"Dr.",name:"Giuseppe",surname:"Viola",slug:"giuseppe-viola",fullName:"Giuseppe Viola"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10584",title:"Engineered Wood Products for Construction",subtitle:null,isOpenForSubmission:!0,hash:"421757c56a3735986055250821275a51",slug:null,bookSignature:"Dr. Meng Gong",coverURL:"https://cdn.intechopen.com/books/images_new/10584.jpg",editedByType:null,editors:[{id:"274242",title:"Dr.",name:"Meng",surname:"Gong",slug:"meng-gong",fullName:"Meng Gong"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10769",title:"Supercapacitors",subtitle:null,isOpenForSubmission:!0,hash:"dda2f53b2c9ee308fe5f3e0d1638ff5c",slug:null,bookSignature:"Associate Prof. Daisuke Tashima and Dr. Aneeya Kumar Samantara",coverURL:"https://cdn.intechopen.com/books/images_new/10769.jpg",editedByType:null,editors:[{id:"254915",title:"Prof.",name:"Daisuke",surname:"Tashima",slug:"daisuke-tashima",fullName:"Daisuke Tashima"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10370",title:"Advances in Fundamental and Applied Research on Spatial Audio",subtitle:null,isOpenForSubmission:!0,hash:"f16232a481c08a05cc191ac64cf2c69e",slug:null,bookSignature:"Dr. Brian FG Katz and Dr. Piotr Majdak",coverURL:"https://cdn.intechopen.com/books/images_new/10370.jpg",editedByType:null,editors:[{id:"278731",title:"Dr.",name:"Brian FG",surname:"Katz",slug:"brian-fg-katz",fullName:"Brian FG Katz"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10681",title:"Biodegradation",subtitle:null,isOpenForSubmission:!0,hash:"9a6e10e02788092872fd249436898e97",slug:null,bookSignature:"Ph.D. Kassio Ferreira Mendes, Dr. Rodrigo Nogueira de Sousa and Dr. Kamila Cabral Mielke",coverURL:"https://cdn.intechopen.com/books/images_new/10681.jpg",editedByType:null,editors:[{id:"197720",title:"Ph.D.",name:"Kassio",surname:"Ferreira Mendes",slug:"kassio-ferreira-mendes",fullName:"Kassio Ferreira Mendes"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10810",title:"Modern Ship Engineering, Design and Operations",subtitle:null,isOpenForSubmission:!0,hash:"579a9da63aca2172c0f0584328ae91c1",slug:null,bookSignature:"Dr. Carlos Alberto Reusser",coverURL:"https://cdn.intechopen.com/books/images_new/10810.jpg",editedByType:null,editors:[{id:"209816",title:"Dr.",name:"Carlos",surname:"Reusser",slug:"carlos-reusser",fullName:"Carlos Reusser"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10856",title:"Crude Oil - New Technologies and Recent Approaches",subtitle:null,isOpenForSubmission:!0,hash:"8d0a7ca35b3de95b295dc4eab39a087e",slug:null,bookSignature:"Prof. Manar El-Sayed Abdel-Raouf and Dr. Mohamed Hasan El-Keshawy",coverURL:"https://cdn.intechopen.com/books/images_new/10856.jpg",editedByType:null,editors:[{id:"102626",title:"Prof.",name:"Manar El-Sayed",surname:"Abdel-Raouf",slug:"manar-el-sayed-abdel-raouf",fullName:"Manar El-Sayed Abdel-Raouf"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10771",title:"Advancements Towards Sustainability of HVAC & R Systems",subtitle:null,isOpenForSubmission:!0,hash:"0718b748e10605d793d244c62797acf4",slug:null,bookSignature:"Dr. Ahmed Niameh Mehdy Alhusseny, Dr. Qahtan Al-Aabidy and Dr. Adel Gharib Nasser",coverURL:"https://cdn.intechopen.com/books/images_new/10771.jpg",editedByType:null,editors:[{id:"208783",title:"Dr.",name:"Ahmed",surname:"Alhusseny",slug:"ahmed-alhusseny",fullName:"Ahmed Alhusseny"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:25},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:7},{group:"topic",caption:"Business, Management and Economics",value:7,count:3},{group:"topic",caption:"Chemistry",value:8,count:11},{group:"topic",caption:"Computer and Information Science",value:9,count:9},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:9},{group:"topic",caption:"Engineering",value:11,count:25},{group:"topic",caption:"Environmental Sciences",value:12,count:3},{group:"topic",caption:"Immunology and Microbiology",value:13,count:4},{group:"topic",caption:"Materials Science",value:14,count:7},{group:"topic",caption:"Mathematics",value:15,count:2},{group:"topic",caption:"Medicine",value:16,count:44},{group:"topic",caption:"Neuroscience",value:18,count:3},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:3},{group:"topic",caption:"Physics",value:20,count:4},{group:"topic",caption:"Psychology",value:21,count:4},{group:"topic",caption:"Robotics",value:22,count:1},{group:"topic",caption:"Social Sciences",value:23,count:3},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:2}],offset:12,limit:12,total:28},popularBooks:{featuredBooks:[{type:"book",id:"8472",title:"Bioactive Compounds in Nutraceutical and Functional Food for Good Human Health",subtitle:null,isOpenForSubmission:!1,hash:"8855452919b8495810ef8e88641feb20",slug:"bioactive-compounds-in-nutraceutical-and-functional-food-for-good-human-health",bookSignature:"Kavita Sharma, Kanchan Mishra, Kula Kamal Senapati and Corina Danciu",coverURL:"https://cdn.intechopen.com/books/images_new/8472.jpg",editors:[{id:"197731",title:"Dr.",name:"Kavita",middleName:null,surname:"Sharma",slug:"kavita-sharma",fullName:"Kavita Sharma"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9685",title:"Agroecosystems",subtitle:"Very Complex Environmental Systems",isOpenForSubmission:!1,hash:"c44f7b43a9f9610c243dc32300d37df6",slug:"agroecosystems-very-complex-environmental-systems",bookSignature:"Marcelo L. Larramendy and Sonia Soloneski",coverURL:"https://cdn.intechopen.com/books/images_new/9685.jpg",editors:[{id:"14764",title:"Dr.",name:"Marcelo L.",middleName:null,surname:"Larramendy",slug:"marcelo-l.-larramendy",fullName:"Marcelo L. Larramendy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8564",title:"Cell Interaction",subtitle:"Molecular and Immunological Basis for Disease Management",isOpenForSubmission:!1,hash:"98d7f080d80524285f091e72a8e92a6d",slug:"cell-interaction-molecular-and-immunological-basis-for-disease-management",bookSignature:"Bhawana Singh",coverURL:"https://cdn.intechopen.com/books/images_new/8564.jpg",editors:[{id:"315192",title:"Dr.",name:"Bhawana",middleName:null,surname:"Singh",slug:"bhawana-singh",fullName:"Bhawana Singh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9629",title:"Electroencephalography",subtitle:"From Basic Research to Clinical Applications",isOpenForSubmission:!1,hash:"8147834b6c6deeeec40f407c71ad60b4",slug:"electroencephalography-from-basic-research-to-clinical-applications",bookSignature:"Hideki Nakano",coverURL:"https://cdn.intechopen.com/books/images_new/9629.jpg",editors:[{id:"196461",title:"Prof.",name:"Hideki",middleName:null,surname:"Nakano",slug:"hideki-nakano",fullName:"Hideki Nakano"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8760",title:"Structure Topology and Symplectic Geometry",subtitle:null,isOpenForSubmission:!1,hash:"8974840985ec3652492c83e20233bf02",slug:"structure-topology-and-symplectic-geometry",bookSignature:"Kamal Shah and Min Lei",coverURL:"https://cdn.intechopen.com/books/images_new/8760.jpg",editors:[{id:"231748",title:"Dr.",name:"Kamal",middleName:null,surname:"Shah",slug:"kamal-shah",fullName:"Kamal Shah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9161",title:"Frailty in the Elderly",subtitle:"Understanding and Managing Complexity",isOpenForSubmission:!1,hash:"a4f0f2fade8fb8ba35c405f5ad31a823",slug:"frailty-in-the-elderly-understanding-and-managing-complexity",bookSignature:"Sara Palermo",coverURL:"https://cdn.intechopen.com/books/images_new/9161.jpg",editors:[{id:"233998",title:"Ph.D.",name:"Sara",middleName:null,surname:"Palermo",slug:"sara-palermo",fullName:"Sara Palermo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8445",title:"Dam Engineering",subtitle:"Recent Advances in Design and Analysis",isOpenForSubmission:!1,hash:"a7e4d2ecbc65d78fa7582e0d2e143906",slug:"dam-engineering-recent-advances-in-design-and-analysis",bookSignature:"Zhongzhi Fu and Erich Bauer",coverURL:"https://cdn.intechopen.com/books/images_new/8445.jpg",editors:[{id:"249577",title:"Dr.",name:"Zhongzhi",middleName:null,surname:"Fu",slug:"zhongzhi-fu",fullName:"Zhongzhi Fu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8937",title:"Soil Moisture Importance",subtitle:null,isOpenForSubmission:!1,hash:"3951728ace7f135451d66b72e9908b47",slug:"soil-moisture-importance",bookSignature:"Ram Swaroop Meena and Rahul Datta",coverURL:"https://cdn.intechopen.com/books/images_new/8937.jpg",editors:[{id:"313528",title:"Associate Prof.",name:"Ram Swaroop",middleName:null,surname:"Meena",slug:"ram-swaroop-meena",fullName:"Ram Swaroop Meena"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7031",title:"Liver Pathology",subtitle:null,isOpenForSubmission:!1,hash:"631321b0565459ed0175917f1c8c727f",slug:"liver-pathology",bookSignature:"Vijay Gayam and Omer Engin",coverURL:"https://cdn.intechopen.com/books/images_new/7031.jpg",editors:[{id:"273100",title:"Dr.",name:"Vijay",middleName:null,surname:"Gayam",slug:"vijay-gayam",fullName:"Vijay Gayam"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8158",title:"Veganism",subtitle:"a Fashion Trend or Food as a Medicine",isOpenForSubmission:!1,hash:"d8e51fc25a379e5b92a270addbb4351d",slug:"veganism-a-fashion-trend-or-food-as-a-medicine",bookSignature:"Miljana Z. Jovandaric",coverURL:"https://cdn.intechopen.com/books/images_new/8158.jpg",editors:[{id:"268043",title:"Dr.",name:"Miljana Z.",middleName:"Z",surname:"Jovandaric",slug:"miljana-z.-jovandaric",fullName:"Miljana Z. Jovandaric"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:5315},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"8472",title:"Bioactive Compounds in Nutraceutical and Functional Food for Good Human Health",subtitle:null,isOpenForSubmission:!1,hash:"8855452919b8495810ef8e88641feb20",slug:"bioactive-compounds-in-nutraceutical-and-functional-food-for-good-human-health",bookSignature:"Kavita Sharma, Kanchan Mishra, Kula Kamal Senapati and Corina Danciu",coverURL:"https://cdn.intechopen.com/books/images_new/8472.jpg",editors:[{id:"197731",title:"Dr.",name:"Kavita",middleName:null,surname:"Sharma",slug:"kavita-sharma",fullName:"Kavita Sharma"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9685",title:"Agroecosystems",subtitle:"Very Complex Environmental Systems",isOpenForSubmission:!1,hash:"c44f7b43a9f9610c243dc32300d37df6",slug:"agroecosystems-very-complex-environmental-systems",bookSignature:"Marcelo L. Larramendy and Sonia Soloneski",coverURL:"https://cdn.intechopen.com/books/images_new/9685.jpg",editors:[{id:"14764",title:"Dr.",name:"Marcelo L.",middleName:null,surname:"Larramendy",slug:"marcelo-l.-larramendy",fullName:"Marcelo L. Larramendy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8564",title:"Cell Interaction",subtitle:"Molecular and Immunological Basis for Disease Management",isOpenForSubmission:!1,hash:"98d7f080d80524285f091e72a8e92a6d",slug:"cell-interaction-molecular-and-immunological-basis-for-disease-management",bookSignature:"Bhawana Singh",coverURL:"https://cdn.intechopen.com/books/images_new/8564.jpg",editors:[{id:"315192",title:"Dr.",name:"Bhawana",middleName:null,surname:"Singh",slug:"bhawana-singh",fullName:"Bhawana Singh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9629",title:"Electroencephalography",subtitle:"From Basic Research to Clinical Applications",isOpenForSubmission:!1,hash:"8147834b6c6deeeec40f407c71ad60b4",slug:"electroencephalography-from-basic-research-to-clinical-applications",bookSignature:"Hideki Nakano",coverURL:"https://cdn.intechopen.com/books/images_new/9629.jpg",editors:[{id:"196461",title:"Prof.",name:"Hideki",middleName:null,surname:"Nakano",slug:"hideki-nakano",fullName:"Hideki Nakano"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8760",title:"Structure Topology and Symplectic Geometry",subtitle:null,isOpenForSubmission:!1,hash:"8974840985ec3652492c83e20233bf02",slug:"structure-topology-and-symplectic-geometry",bookSignature:"Kamal Shah and Min Lei",coverURL:"https://cdn.intechopen.com/books/images_new/8760.jpg",editors:[{id:"231748",title:"Dr.",name:"Kamal",middleName:null,surname:"Shah",slug:"kamal-shah",fullName:"Kamal Shah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9161",title:"Frailty in the Elderly",subtitle:"Understanding and Managing Complexity",isOpenForSubmission:!1,hash:"a4f0f2fade8fb8ba35c405f5ad31a823",slug:"frailty-in-the-elderly-understanding-and-managing-complexity",bookSignature:"Sara Palermo",coverURL:"https://cdn.intechopen.com/books/images_new/9161.jpg",editors:[{id:"233998",title:"Ph.D.",name:"Sara",middleName:null,surname:"Palermo",slug:"sara-palermo",fullName:"Sara Palermo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8445",title:"Dam Engineering",subtitle:"Recent Advances in Design and Analysis",isOpenForSubmission:!1,hash:"a7e4d2ecbc65d78fa7582e0d2e143906",slug:"dam-engineering-recent-advances-in-design-and-analysis",bookSignature:"Zhongzhi Fu and Erich Bauer",coverURL:"https://cdn.intechopen.com/books/images_new/8445.jpg",editors:[{id:"249577",title:"Dr.",name:"Zhongzhi",middleName:null,surname:"Fu",slug:"zhongzhi-fu",fullName:"Zhongzhi Fu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8937",title:"Soil Moisture Importance",subtitle:null,isOpenForSubmission:!1,hash:"3951728ace7f135451d66b72e9908b47",slug:"soil-moisture-importance",bookSignature:"Ram Swaroop Meena and Rahul Datta",coverURL:"https://cdn.intechopen.com/books/images_new/8937.jpg",editors:[{id:"313528",title:"Associate Prof.",name:"Ram Swaroop",middleName:null,surname:"Meena",slug:"ram-swaroop-meena",fullName:"Ram Swaroop Meena"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7031",title:"Liver Pathology",subtitle:null,isOpenForSubmission:!1,hash:"631321b0565459ed0175917f1c8c727f",slug:"liver-pathology",bookSignature:"Vijay Gayam and Omer Engin",coverURL:"https://cdn.intechopen.com/books/images_new/7031.jpg",editors:[{id:"273100",title:"Dr.",name:"Vijay",middleName:null,surname:"Gayam",slug:"vijay-gayam",fullName:"Vijay Gayam"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"8472",title:"Bioactive Compounds in Nutraceutical and Functional Food for Good Human Health",subtitle:null,isOpenForSubmission:!1,hash:"8855452919b8495810ef8e88641feb20",slug:"bioactive-compounds-in-nutraceutical-and-functional-food-for-good-human-health",bookSignature:"Kavita Sharma, Kanchan Mishra, Kula Kamal Senapati and Corina Danciu",coverURL:"https://cdn.intechopen.com/books/images_new/8472.jpg",editedByType:"Edited by",editors:[{id:"197731",title:"Dr.",name:"Kavita",middleName:null,surname:"Sharma",slug:"kavita-sharma",fullName:"Kavita Sharma"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8760",title:"Structure Topology and Symplectic Geometry",subtitle:null,isOpenForSubmission:!1,hash:"8974840985ec3652492c83e20233bf02",slug:"structure-topology-and-symplectic-geometry",bookSignature:"Kamal Shah and Min Lei",coverURL:"https://cdn.intechopen.com/books/images_new/8760.jpg",editedByType:"Edited by",editors:[{id:"231748",title:"Dr.",name:"Kamal",middleName:null,surname:"Shah",slug:"kamal-shah",fullName:"Kamal Shah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9536",title:"Education at the Intersection of Globalization and Technology",subtitle:null,isOpenForSubmission:!1,hash:"0cf6891060eb438d975d250e8b127ed6",slug:"education-at-the-intersection-of-globalization-and-technology",bookSignature:"Sharon Waller, Lee Waller, Vongai Mpofu and Mercy Kurebwa",coverURL:"https://cdn.intechopen.com/books/images_new/9536.jpg",editedByType:"Edited by",editors:[{id:"263302",title:"Dr.",name:"Sharon",middleName:null,surname:"Waller",slug:"sharon-waller",fullName:"Sharon Waller"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8564",title:"Cell Interaction",subtitle:"Molecular and Immunological Basis for Disease Management",isOpenForSubmission:!1,hash:"98d7f080d80524285f091e72a8e92a6d",slug:"cell-interaction-molecular-and-immunological-basis-for-disease-management",bookSignature:"Bhawana Singh",coverURL:"https://cdn.intechopen.com/books/images_new/8564.jpg",editedByType:"Edited by",editors:[{id:"315192",title:"Dr.",name:"Bhawana",middleName:null,surname:"Singh",slug:"bhawana-singh",fullName:"Bhawana Singh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9629",title:"Electroencephalography",subtitle:"From Basic Research to Clinical Applications",isOpenForSubmission:!1,hash:"8147834b6c6deeeec40f407c71ad60b4",slug:"electroencephalography-from-basic-research-to-clinical-applications",bookSignature:"Hideki Nakano",coverURL:"https://cdn.intechopen.com/books/images_new/9629.jpg",editedByType:"Edited by",editors:[{id:"196461",title:"Prof.",name:"Hideki",middleName:null,surname:"Nakano",slug:"hideki-nakano",fullName:"Hideki Nakano"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9685",title:"Agroecosystems",subtitle:"Very Complex Environmental Systems",isOpenForSubmission:!1,hash:"c44f7b43a9f9610c243dc32300d37df6",slug:"agroecosystems-very-complex-environmental-systems",bookSignature:"Marcelo L. Larramendy and Sonia Soloneski",coverURL:"https://cdn.intechopen.com/books/images_new/9685.jpg",editedByType:"Edited by",editors:[{id:"14764",title:"Dr.",name:"Marcelo L.",middleName:null,surname:"Larramendy",slug:"marcelo-l.-larramendy",fullName:"Marcelo L. Larramendy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9524",title:"Organ Donation and Transplantation",subtitle:null,isOpenForSubmission:!1,hash:"6ef47e03cd4e6476946fc28ca51de825",slug:"organ-donation-and-transplantation",bookSignature:"Vassil Mihaylov",coverURL:"https://cdn.intechopen.com/books/images_new/9524.jpg",editedByType:"Edited by",editors:[{id:"313113",title:"Associate Prof.",name:"Vassil",middleName:null,surname:"Mihaylov",slug:"vassil-mihaylov",fullName:"Vassil Mihaylov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9280",title:"Underwater Work",subtitle:null,isOpenForSubmission:!1,hash:"647b4270d937deae4a82f5702d1959ec",slug:"underwater-work",bookSignature:"Sérgio António Neves Lousada",coverURL:"https://cdn.intechopen.com/books/images_new/9280.jpg",editedByType:"Edited by",editors:[{id:"248645",title:"Dr.",name:"Sérgio António",middleName:null,surname:"Neves Lousada",slug:"sergio-antonio-neves-lousada",fullName:"Sérgio António Neves Lousada"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9161",title:"Frailty in the Elderly",subtitle:"Understanding and Managing Complexity",isOpenForSubmission:!1,hash:"a4f0f2fade8fb8ba35c405f5ad31a823",slug:"frailty-in-the-elderly-understanding-and-managing-complexity",bookSignature:"Sara Palermo",coverURL:"https://cdn.intechopen.com/books/images_new/9161.jpg",editedByType:"Edited by",editors:[{id:"233998",title:"Ph.D.",name:"Sara",middleName:null,surname:"Palermo",slug:"sara-palermo",fullName:"Sara Palermo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8158",title:"Veganism",subtitle:"a Fashion Trend or Food as a Medicine",isOpenForSubmission:!1,hash:"d8e51fc25a379e5b92a270addbb4351d",slug:"veganism-a-fashion-trend-or-food-as-a-medicine",bookSignature:"Miljana Z. Jovandaric",coverURL:"https://cdn.intechopen.com/books/images_new/8158.jpg",editedByType:"Edited by",editors:[{id:"268043",title:"Dr.",name:"Miljana Z.",middleName:"Z",surname:"Jovandaric",slug:"miljana-z.-jovandaric",fullName:"Miljana Z. Jovandaric"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"1060",title:"Physiopathology",slug:"physiopathology",parent:{title:"Mental and Behavioural Disorders and Diseases of the Nervous System",slug:"mental-and-behavioural-disorders-and-diseases-of-the-nervous-system"},numberOfBooks:1,numberOfAuthorsAndEditors:21,numberOfWosCitations:11,numberOfCrossrefCitations:5,numberOfDimensionsCitations:13,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"physiopathology",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"774",title:"Perinatal Depression",subtitle:null,isOpenForSubmission:!1,hash:"412484bd347149e42a5a379523c534db",slug:"perinatal-depression",bookSignature:"María Graciela Rojas Castillo",coverURL:"https://cdn.intechopen.com/books/images_new/774.jpg",editedByType:"Edited by",editors:[{id:"93924",title:"Dr.",name:"María Graciela",middleName:null,surname:"Rojas Castillo",slug:"maria-graciela-rojas-castillo",fullName:"María Graciela Rojas Castillo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:1,mostCitedChapters:[{id:"26569",doi:"10.5772/31664",title:"Screening and Prevention of Postnatal Depression",slug:"screening-and-prevention-of-postnatal-depression",totalDownloads:3546,totalCrossrefCites:3,totalDimensionsCites:5,book:{slug:"perinatal-depression",title:"Perinatal Depression",fullTitle:"Perinatal Depression"},signatures:"Kari Glavin",authors:[{id:"88173",title:"Dr.",name:"Kari",middleName:null,surname:"Glavin",slug:"kari-glavin",fullName:"Kari Glavin"}]},{id:"26577",doi:"10.5772/30854",title:"Postpartum Depression in Men",slug:"postpartum-depression-in-men-",totalDownloads:4273,totalCrossrefCites:0,totalDimensionsCites:3,book:{slug:"perinatal-depression",title:"Perinatal Depression",fullTitle:"Perinatal Depression"},signatures:"Sarah J. Breese McCoy",authors:[{id:"84527",title:"Dr.",name:"Sarah",middleName:null,surname:"Breese McCoy",slug:"sarah-breese-mccoy",fullName:"Sarah Breese McCoy"}]},{id:"26571",doi:"10.5772/32351",title:"Perinatal Anxiety and Depression: Associations with Oxytocin and Mother-Infant Interactions",slug:"perinatal-anxiety-and-depression-associations-with-oxytocin-and-mother-infant-interactions-",totalDownloads:2225,totalCrossrefCites:1,totalDimensionsCites:2,book:{slug:"perinatal-depression",title:"Perinatal Depression",fullTitle:"Perinatal Depression"},signatures:"Rebecca McErlean and Valsamma Eapen",authors:[{id:"62816",title:"Dr.",name:"Valsamma",middleName:null,surname:"Eapen",slug:"valsamma-eapen",fullName:"Valsamma Eapen"},{id:"125965",title:"Ms.",name:"Rebecca",middleName:null,surname:"McErlean",slug:"rebecca-mcerlean",fullName:"Rebecca McErlean"}]}],mostDownloadedChaptersLast30Days:[{id:"26577",title:"Postpartum Depression in Men",slug:"postpartum-depression-in-men-",totalDownloads:4272,totalCrossrefCites:0,totalDimensionsCites:3,book:{slug:"perinatal-depression",title:"Perinatal Depression",fullTitle:"Perinatal Depression"},signatures:"Sarah J. Breese McCoy",authors:[{id:"84527",title:"Dr.",name:"Sarah",middleName:null,surname:"Breese McCoy",slug:"sarah-breese-mccoy",fullName:"Sarah Breese McCoy"}]},{id:"26576",title:"Perinatal Depression in Minority and Underserved Rural Women",slug:"perinatal-depression-in-minority-and-underserved-rural-women",totalDownloads:3704,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"perinatal-depression",title:"Perinatal Depression",fullTitle:"Perinatal Depression"},signatures:"Guo Wei, Frankie D. Powell, Veronica K. Freeman and Leonard D. Holmes",authors:[{id:"92913",title:"Prof.",name:"Guo",middleName:null,surname:"Wei",slug:"guo-wei",fullName:"Guo Wei"},{id:"106609",title:"Dr.",name:"Frankie",middleName:null,surname:"Powell",slug:"frankie-powell",fullName:"Frankie Powell"},{id:"126129",title:"Mrs.",name:"Veronica",middleName:"Kay",surname:"Freeman",slug:"veronica-freeman",fullName:"Veronica Freeman"},{id:"136213",title:"Dr.",name:"Leonard",middleName:"Darrow",surname:"Holmes",slug:"leonard-holmes",fullName:"Leonard Holmes"}]},{id:"26575",title:"Postpartum Depression and Maternity Blues in Immigrants",slug:"postpartum-depression-and-maternity-blues-in-immigrants",totalDownloads:3532,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"perinatal-depression",title:"Perinatal Depression",fullTitle:"Perinatal Depression"},signatures:"Fragiskos Gonidakis",authors:[{id:"84754",title:"Dr.",name:"Fragiskos",middleName:null,surname:"Gonidakis",slug:"fragiskos-gonidakis",fullName:"Fragiskos Gonidakis"}]},{id:"26570",title:"Prelude to Parenthood: The Impact of Anxiety and Depression During Pregnancy",slug:"prelude-to-parenthood-the-impact-of-anxiety-and-depression-during-pregnancy",totalDownloads:2238,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"perinatal-depression",title:"Perinatal Depression",fullTitle:"Perinatal Depression"},signatures:"Carol Cornsweet Barber",authors:[{id:"90052",title:"Dr.",name:"Carol Cornsweet",middleName:null,surname:"Barber",slug:"carol-cornsweet-barber",fullName:"Carol Cornsweet Barber"}]},{id:"26574",title:"Postnatal Depression and Emotion: The Misfortune of Mother-Infant Interactions",slug:"postnatal-depression-and-emotion-the-misfortune-of-mother-infant-interactions-",totalDownloads:2219,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"perinatal-depression",title:"Perinatal Depression",fullTitle:"Perinatal Depression"},signatures:"Sandrine Gil, Sylvie Droit-Volet, Virginie Laval and Frédérique Teissèdre",authors:[{id:"84456",title:"Dr.",name:"Sandrine",middleName:null,surname:"Gil",slug:"sandrine-gil",fullName:"Sandrine Gil"},{id:"124802",title:"Prof.",name:"Sylvie",middleName:null,surname:"Droit-Volet",slug:"sylvie-droit-volet",fullName:"Sylvie Droit-Volet"},{id:"124803",title:"Dr.",name:"Frédérique",middleName:null,surname:"Teissèdre",slug:"frederique-teissedre",fullName:"Frédérique Teissèdre"},{id:"126826",title:"Prof.",name:"Virginie",middleName:null,surname:"Laval",slug:"virginie-laval",fullName:"Virginie Laval"}]},{id:"26571",title:"Perinatal Anxiety and Depression: Associations with Oxytocin and Mother-Infant Interactions",slug:"perinatal-anxiety-and-depression-associations-with-oxytocin-and-mother-infant-interactions-",totalDownloads:2225,totalCrossrefCites:1,totalDimensionsCites:2,book:{slug:"perinatal-depression",title:"Perinatal Depression",fullTitle:"Perinatal Depression"},signatures:"Rebecca McErlean and Valsamma Eapen",authors:[{id:"62816",title:"Dr.",name:"Valsamma",middleName:null,surname:"Eapen",slug:"valsamma-eapen",fullName:"Valsamma Eapen"},{id:"125965",title:"Ms.",name:"Rebecca",middleName:null,surname:"McErlean",slug:"rebecca-mcerlean",fullName:"Rebecca McErlean"}]},{id:"26573",title:"Employment During Pregnancy Protects Against Postpartum Depression",slug:"employment-during-pregnancy-protects-against-postpartum-depression",totalDownloads:1673,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"perinatal-depression",title:"Perinatal Depression",fullTitle:"Perinatal Depression"},signatures:"Elisabet Vilella, Glòria Albacar, Rocío Martín-Santos, Lluïsa García-Esteve, Roser Guillamat, Julio Sanjuan, Francesca Cañellas, Isolde Gornemann, Yolanda de Diego, Ana Gaviria and Alfonso Gutiérrez-Zotes",authors:[{id:"84586",title:"Dr.",name:"Elisabet",middleName:null,surname:"Vilella",slug:"elisabet-vilella",fullName:"Elisabet Vilella"}]},{id:"26569",title:"Screening and Prevention of Postnatal Depression",slug:"screening-and-prevention-of-postnatal-depression",totalDownloads:3546,totalCrossrefCites:3,totalDimensionsCites:5,book:{slug:"perinatal-depression",title:"Perinatal Depression",fullTitle:"Perinatal Depression"},signatures:"Kari Glavin",authors:[{id:"88173",title:"Dr.",name:"Kari",middleName:null,surname:"Glavin",slug:"kari-glavin",fullName:"Kari Glavin"}]},{id:"26572",title:"Postnatal Depression: When Reality Does Not Match Expectations",slug:"postnatal-depression-when-reality-does-not-match-expectations",totalDownloads:3646,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"perinatal-depression",title:"Perinatal Depression",fullTitle:"Perinatal Depression"},signatures:"Carol Kauppi, Phyllis Montgomery, Arshi Shaikh and Tamara White",authors:[{id:"93628",title:"Dr.",name:"Carol",middleName:null,surname:"Kauppi",slug:"carol-kauppi",fullName:"Carol Kauppi"},{id:"127630",title:"Dr.",name:"Phyllis",middleName:null,surname:"Montgomery",slug:"phyllis-montgomery",fullName:"Phyllis Montgomery"},{id:"127631",title:"Ms.",name:"Arshi",middleName:null,surname:"Shaikh",slug:"arshi-shaikh",fullName:"Arshi Shaikh"},{id:"127632",title:"Ms.",name:"Tamara",middleName:null,surname:"White",slug:"tamara-white",fullName:"Tamara White"}]},{id:"26578",title:"Risk Factors of Postnatal Depression Among Immigrants in Norway",slug:"risk-factors-of-postnatal-depression-among-immigrants-in-norway",totalDownloads:1997,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"perinatal-depression",title:"Perinatal Depression",fullTitle:"Perinatal Depression"},signatures:"Soen Eng Yap and Babill Stray-Pedersen",authors:[{id:"89513",title:"Dr.",name:"Soen Eng",middleName:null,surname:"Yap (Bjerke)",slug:"soen-eng-yap-(bjerke)",fullName:"Soen Eng Yap (Bjerke)"}]}],onlineFirstChaptersFilter:{topicSlug:"physiopathology",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"profile.detail",path:"/profiles/273142/jose-abella",hash:"",query:{},params:{id:"273142",slug:"jose-abella"},fullPath:"/profiles/273142/jose-abella",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()